EurekaMag Full Text Articles Chapter 44,109

Gould, A.R.; Miller, C.H.; Kafrawy, A.H. 1981: Pyran copolymer and 7,12-dimethylbenzanthracene-induced carcinogenesis in the hamster cheek pouch. Archives of Oral Biology 26(10): 761-767

Zander, A.R.; Spitzer, G.; Verma, D.S.; Ginzbarg, S.; Dicke, K.A. 1980: Pyran copolymer: effect of molecular weight on stem cell mobilization in mice. Biomedicine / 33(3): 69-72

Clement, N.R.; Gould, J.M. 1981: Pyranine (8-hydroxy-1,3,6-pyrenetrisulfonate) as a probe of internal aqueous hydrogen ion concentration in phospholipid vesicles. Biochemistry 20(6): 1534-1538

Etzold, G.; Langen, P. 1966: Pyranoid isomers of alpha and beta thymidine. Die Naturwissenschaften 53(7): 178

Etzold, G.; Hintsche, R.; Langen, P. 1967: Pyranoide thymine-O2.3'-cyclonucleosides. Tetrahedron Letters 48: 4827-4830

Carney, D.E.; O'Reilly, B.J.; Tweddell, E.D. 1971: Pyrantel embonate in the treatment of enterobiasis. Medical Journal of Australia 2(5): 254-256

Eshima, N.; Fujii, S.; Murotsu, T.; Horiuchi, T. 1972: Lambda phage mutants insensitive to temperature-sensitive repressor. 3. Effects of virL, virR or virC mutation on the gene expression. Molecular and General Genetics: Mgg 116(1): 84-87

Pawlowski, Z.; Chwirot, E.; Zizlawski, J. 1973: Pyrantel--a new drug in enterobiasis. Polski Tygodnik Lekarski 28(8): 291-293

Poschel, B.P.; McCarthy, D.A.; Chen, G.; Ensor, C.R. 1974: Pyrazapon (CI-683): a new antianxiety agent. Psychopharmacologia 35(3): 257-271

Zapletálek, M.; Libiger, J.; Kaspárková, E.; Tůma, I.; Domkár, J. 1981: Pyrazidole in the treatment of endogenous depression: controlled study. Ceskoslovenska Psychiatrie 77(1): 31-37

Forgan-Smith, R.; Ellard, G.A.; Newton, D.; Mitchison, D.A. 1973: Pyrazinamide and other drugs in tuberculous meningitis. Lancet 2(7825): 374

Danan, G.; Pessayre, D.; Larrey, D.; Benhamou, J.P. 1981: Pyrazinamide fulminant hepatitis: an old hepatotoxin strikes again. Lancet 2(8254): 1056-1057

Pretet, S.; Liard, R.; Perdrizet, S. 1982: Pyrazinamide is a major antituberculosis drug. Lancet 1(8268): 399

Konno, K.; Feldmann, F.M.; McDermott, W. 1967: Pyrazinamide susceptibility and amidase activity of tubercle bacilli. American Review of Respiratory Disease 95(3): 461-469

Fiala, W.; Häcki, M.A.; Brändli, O. 1983: Pyrazinamide versus ethambutol in short-term therapy of lung tuberculosis. a randomized study. Schweizerische Medizinische Wochenschrift 113(51): 1956-1959

Aspevik, E. 1967: Pyrazinamide, cycloserine and ethionamide in the complex treatment of pulmonary tuberculosis. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 87(6): 548-554

Frati, H.J.; Grobli, C.W. 1965: Pyrazinamide; its toxicity. Revista de la Sanidad Militar Argentina 64(1): 60-61

Bicking, J.B.; Robb, C.M.; Kwong, S.F.; Cragoe, E.J. 1967: Pyrazine diuretics. 3. 5- and 6-alkyl, -cycloalkyl, and -aryl derivatives of n-amidino-3-aminopyrazinecarboxamides. Journal of Medicinal Chemistry 10(4): 598-602

Jones, J.H.; Cragoe, E.J. 1970: Pyrazine diuretics. 8. N-Amidino-3-aminopyrazinecarboxamide 4-oxides. Journal of Medicinal Chemistry 13(5): 987-989

Jones, J.H.; Bicking, J.B.; Cragoe, E.J. 1967: Pyrazine diuretics. IV. N-amidino-3-amino-6-substituted pyrazinecarboxamides. Journal of Medicinal Chemistry 10(5): 899-903

Jones, J.H.; Cragoe, E.J. 1968: Pyrazine diuretics. V. N-Amidino-3-aminopyrazinecarboxamidines and analogous 2,4-diaminopteridines. Journal of Medicinal Chemistry 11(2): 322-325

Shepard, K.L.; Mason, J.W.; Woltersdorf, O.W.; Jones, J.H.; Cragoe, E.J. 1969: Pyrazine diuretics. VI. (Pyrazinecarboxamido)guanidines. Journal of Medicinal Chemistry 12(2): 280-285

Jones, J.H.; Holtz, W.J.; Cragoe, E.J. 1969: Pyrazine diuretics. VII. N-amidino-3-substituted pyrazinecarboxamides. Journal of Medicinal Chemistry 12(2): 285-287

Gatta, F.; Zaccari, V.; Huidobro-Toro, J.P.; Landi Vittory, R. 1974: Pyrazine-1,2-a-and 1,4-diazepino-1-2-1-indoles. I. Synthesis of 10-phenyl-1,2,3,4-yrytshyftopytsxino-1,2-a-indoles and of 11-phenyl-2,3,4,5-tetrahydro-1H-1,4-diazepino-1,2-a-indoles. Il Farmaco; Edizione Scientifica 29(5): 386-397

Binder, D.; Georgopoulos, A.; Noe, C.R.; Nussbaumer, J.; Prager, B.C.; Turnowsky, F. 1982: Pyrazine-1,4-dioxides fused to heterocycles / 2nd comm.: Synthesis and antibacterial activity of substituted pyrido[2,3-b]pyrazine-1,4-dioxides. Arzneimittel-Forschung 32(1): 10-14

Nicolas, P. 1971: Pyrazinobutazone in conservative dentistry. Le Chirurgien-Dentiste de France 41(93): 61-62

Fournie, A.; Ayrolles, C. 1972: Pyrazinobutazone in rheumatology (Clinical study of 50 cases). Rhumatologie 24(7): 287-291

Commissionat, Y.; Daieff, C.Y. 1973: Pyrazinobutazone its activity in stomatology. Revue d'Odonto-Stomatologie 20(1): 77-78

Worzalla, J.F.; Sweeney, M.J. 1980: Pyrazofurin inhibition of purine biosynthesis via 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranosyl 5'-monophosphate formyltransferase. Cancer Research 40(5): 1482-1485

Suttle, D.P.; Harkrader, R.J.; Jackson, R.C. 1981: Pyrazofurin-resistant hepatoma cells deficient in adenosine kinase. European Journal of Cancer 17(1): 43-51

Feldstein, A.; Kurcharski, J.M. 1971: Pyrazole and ethanol potentiation of tryptophol-induced sleep in mice. Life Sciences. Pt. 1: Physiology and Pharmacology 10(17): 961-967

Bustos, G.O.; Kalant, H.; Khanna, J.M.; Loth, J. 1970: Pyrazole and induction of fatty liver by a single dose of ethanol. Science 168(3939): 1598-1599

Eklund, H.; Samama, J.P.; Wallén, L. 1982: Pyrazole binding in crystalline binary and ternary complexes with liver alcohol dehydrogenase. Biochemistry 21(20): 4858-4866

D'Acosta, N.; Castro, J.A.; de Ferreyra, E.C.; Díaz Gómez, M.I.; de Castro, C.R. 1972: Pyrazole blockade of carbon tetrachloride activation and liver necrosis. Research Communications in Chemical Pathology and Pharmacology 4(3): 641-650

Evarts, R.P.; Raab, M.M.; Haliday, E.; Brown, C. 1983: Pyrazole effects on mutagenicity and toxicity of dimethylnitrosamine in Wistar rats. Cancer Research 43(2): 496-499

Bernacchi, A.S.; de Castro, C.R.; de Toranzo, E.G.; Marzi, A.; de Ferreyra, E.C.; de Fenos, O.M.; Castro, J.A. 1980: Pyrazole prevention of CC14-induced ultrastructural changes in rat liver. British Journal of Experimental Pathology 61(5): 505-511

Witiak, D.T.; Sinha, B.K. 1970: Pyrazole product ratio analysis of the reaction of diazomethane with methyl cis- and trans-beta-chloroacrylates. Journal of Organic Chemistry 35(2): 501-503

Alberti, C.; Tironi, C. 1967: Pyrazole sulfanilamides. X. Nitro-derivatives of 1-phenyl-5-sulfanilamidopyrazole and of 1-phenyl-3-methyl-5-sulfanilamidopyraole. Il Farmaco; Edizione Scientifica 22(6): 418-430

Alberti, C.; Tironi, C. 1971: Pyrazole sulfanilamides. XI. Ethoxy derivatives of phenyl-3-sulfanilamidopyrazole, phenyl-4-sulphanilamidopyrazole, 1-phenyl-5-sulfanilamidopyrazole, 1-phenyl-3-methyl-5-sulfanilamidopyrazole. Il Farmaco; Edizione Scientifica 26(1): 66-88

Alberti, C.; Tironi, C. 1971: Pyrazole sulfanilamides. XII. Amino derivatives of 1-phenyl-5-sulfanilamidopyrazole and of 1-phenyl-3-methyl-5-sulfanilamidopyrazole. Il Farmaco; Edizione Scientifica 26(3): 226-232

Tu, Y.Y.; Sonnenberg, J.; Lewis, K.F.; Yang, C.S. 1981: Pyrazole-induced cytochrome P-450 in rat liver microsomes: an isozyme with high affinity for dimethylnitrosamine. Biochemical and Biophysical Research Communications 103(3): 905-912

Singlevich, T.E.; Barboriak, J.J. 1971: Pyrazole-induced inhibition of yeast alcohol dehydrogenase. Biochemical Pharmacology 20(8): 2087-2089

Skurský, L.; Khayrollah, A. 1980: Pyrazole-insensitive alcohol dehydrogenase activity in human serum. Drug and Alcohol Dependence 6(3): 187-190

Noell, C.W.; Cheng, C.C. 1969: Pyrazoles. 3. Antileukemic activity of 3-(3,3-dimethyl-1-triazeno)pyrazole-4-carboxamide. Journal of Medicinal Chemistry 12(3): 545-546

Noell, C.W.; Cheng, C.C. 1971: Pyrazoles. 4. Analogs of 3-(3,3-dimethyl-1-triazeno)pyrazole-4-carboxamide. Journal of Medicinal Chemistry 14(12): 1245-1246

Cheng, C.C.; Robins, R.K.; Cheng, K.C.; Lin, D.C. 1968: Pyrazoles. I. Synthesis of 4-hydroxypyrazolo[3,4-d]-v-triazine. a new analog of hypoxanthine. Journal of Pharmaceutical Sciences 57(6): 1044-1045

Lotti, B.; Vezzosi, O. 1972: Pyrazolic derivatives with hypoglycemic activity. Il Farmaco; Edizione Scientifica 27(4): 313-316

Alberti, C.; Tironi, C. 1966: Pyrazolic sulfanilamides. 8. Chloro-derivatives of 1-phenyl-4-sulfanilamidopyrazole. Il Farmaco; Edizione Scientifica 21(2): 883-891

Alberti, C.; Tironi, C. 1967: Pyrazolic sulfanilamides. IX. Chloro-, methyl- and methoxy-derivatives of 1-phenyl-5-sulfanilamido-pyrazole. Il Farmaco; Edizione Scientifica 22(1): 58-75

Alberti, C.; Tironi, C. 1974: Pyrazolic sulfanilamides. XIII. Hydroxyderivatives of 1-phenyl-3-sulfanilamidopyrazole and 1-phenyl-4-sulfanilamidopyrazole. Il Farmaco; Edizione Scientifica 29(12): 957-966

Janousek, O.; Rejholec, V. 1970: Pyrazolidine preparations of Czechoslovak origin and their differentiated use in practice. Casopis Lekaru Ceskych 109(50): 1178-1179

Chraibi, A.; Fillion, H.; Luu Duc, C. 1980: Pyrazolidine-diones. I. Synthesis of benzylmalonyl and aryl cyclopropyl dihydrazides. Annales Pharmaceutiques Francaises 38(4): 343-352

Chraibi, A.; Luu-Duc, C.; Chantegrel, J. 1983: Pyrazolidinediones. III. O-Acetyl and N-acetyl derivatives. Synthesis and structural study. Annales Pharmaceutiques Francaises 41(1): 45-53

Nardi, D.; Massarani, E.; Magistretti, M.J. 1969: Pyrazoline-5-one and pyrazolidine-3, 5-dione derivatives with antiphlogistic and analgesic activity. Arzneimittel-Forschung 19(10): 1721-1723

Davies, L.P.; Brown, D.J.; Chow, S.C.; Johnston, G.A. 1983: Pyrazolo [3,4-d] pyrimidines, a new class of adenosine antagonists. Neuroscience Letters 41(1-2): 189-193

Denzel, T.; Höhn, H. 1973: Pyrazolo(4.3-c)pyridines. Archiv der Pharmazie 306(10): 746-751

Lindner, H.J.; Schaden, G. 1972: Pyrazolo(4.3-e)as-triazine, a new heterocyclic system from Pseudomonas fluorescens Var. Pseudoiodinum. Chemische Berichte 105(6): 1949-1955

Becking, G.C.; Johnson, W.J. 1969: Pyrazolo- and triazolopyrimidines as inhibitors of tryptophan pyrrolase. Life Sciences 8(16): 843-851

Loew, G.; Toll, L.; Lawson, J.; Uyeno, E.; Kaegi, H. 1984: Pyrazolo[1,5-a]pyrimidines: receptor binding and anxiolytic behavioral studies. Pharmacology Biochemistry and Behavior 20(3): 343-348

Krenitsky, T.A.; Rideout, J.L.; Koszalka, G.W.; Inmon, R.B.; Chao, E.Y.; Elion, G.B.; Latter, V.S.; Williams, R.B. 1982: Pyrazolo[3,4-d]pyrimidine ribonucleosides as anticoccidials. 1. Synthesis and activity of some nucleosides of purines and 4-(alkylthio)pyrazolo[3,4-d]pyrimidines. Journal of Medicinal Chemistry 25(1): 32-35

Rideout, J.L.; Krenitsky, T.A.; Koszalka, G.W.; Cohn, N.K.; Chao, E.Y.; Elion, G.B.; Latter, V.S.; Williams, R.B. 1982: Pyrazolo[3,4-d]pyrimidine ribonucleosides as anticoccidials. 2. Synthesis and activity of some nucleosides of 4-(alkylamino)-1H-pyrazolo[3, 4-d]pyrimidines. Journal of Medicinal Chemistry 25(9): 1040-1044

Rideout, J.L.; Krenitsky, T.A.; Chao, E.Y.; Elion, G.B.; Williams, R.B.; Latter, V.S. 1983: Pyrazolo[3,4-d]pyrimidine ribonucleosides as anticoccidials. 3. Synthesis and activity of some nucleosides of 4-[(arylalkenyl)thio]pyrazolo[3,4-d]pyrimidines. Journal of Medicinal Chemistry 26(10): 1489-1494

Davies, L.P.; Chow, S.C.; Skerritt, J.H.; Brown, D.J.; Johnston, G.A. 1984: Pyrazolo[3,4-d]pyrimidines as adenosine antagonists. Life Sciences 34(22): 2117-2128

Baraldi, P.G.; Simoni, D.; Periotto, V.; Manfredini, S.; Guarneri, M.; Manservigi, R.; Cassai, E.; Bertolasi, V. 1984: Pyrazolo[4,3-d]pyrimidine nucleosides. Synthesis and antiviral activity of 1-beta-D-ribofuranosyl-3-methyl-6-substituted-7H-pyrazolo[4,3-d]pyr imi din-7-ones. Journal of Medicinal Chemistry 27(8): 986-990

Sircar, J.C.; Capiris, T.; Kesten, S.J.; Herzig, D.J. 1981: Pyrazolo[5,1-b]quinazolin-9-ones: a new series of antiallergic agents. Journal of Medicinal Chemistry 24(6): 735-742

DeWald, H.A.; Nordin, I.C.; L'Italien, Y.J.; Parcell, R.F. 1973: Pyrazolodiazepines. 1,3-(and 2,3-) dialkyl-4,6-dihydro-8-arylpyrazolo(4,3-e)(1,4)diazepin-5-ones as antianxiety agents. Journal of Medicinal Chemistry 16(12): 1346-1354

DeWald, H.A.; Lobbestael, S.; Poschel, B.P. 1981: Pyrazolodiazepines. 3. 4-Aryl-1,6,7,8-tetrahydro-1,3-dialkylpyrazolo[3,4-e][1,4]diazepines as antidepressant agents. Journal of Medicinal Chemistry 24(8): 982-987

Beritić, T. 1969: Pyrazolone agranulocytoses in the world and in Yugoslavia. Lijecnicki Vjesnik 91(4): 439-442

Cervini, C. 1972: Pyrazolones: undesired effects. La Clinica Terapeutica 60(4): 305-318

Bhat, G.A.; Montero, J.L.; Panzica, R.P.; Wotring, L.L.; Townsend, L.B. 1981: Pyrazolopyrimidine nucleosides. 12. Synthesis and biological activity of certain pyrazolo[3,4-d]pyrimidine nucleosides related to adenosine. Journal of Medicinal Chemistry 24(10): 1165-1172

Earl, R.A.; Panzica, R.P.; Townsend, L.B. 1972: Pyrazolopyrimidine nucleosides. 3. Synthesis of 1- and 2-( -D-ribofuranosyl)pyrazolo(3,4-d)pyrimidines from pyrazole nucleoside derivatives. Journal of the Chemical Society. Perkin Transactions 1 21: 2672-2677

Milne, G.H.; Townsend, L.B. 1972: Pyrazolopyrimidine nucleosides. IV. Synthesis and chemical reactivity of the C-nucleoside selenoformycin B and derivatives. Journal of the Chemical Society. Perkin Transactions 1 21: 2677-2681

Revankar, G.R.; Townsend, L.B. 1971: Pyrazolopyrimidine nucleosides. Part I. Synthesis of pyrazolopyrimidine nucleosides related to the nucleoside antibiotic tubercidin. Journal of the Chemical Society. Perkin Transactions 1 13: 2440-2442

Long, R.A.; Lewis, A.F.; Robins, R.K.; Townsend, L.B. 1971: Pyrazolopyrimidine nucleosides. Part II. 7-Substituted 3- -D-ribofuranosylpyrasolo(4,3-d)pyrimidines related to and derived from the nucleoside antibiotics formycin and formycin B. Journal of the Chemical Society. Perkin Transactions 1 13: 2443-2446

Townsend, L.B.; Long, R.A.; McGraw, J.P.; Miles, D.W.; Robins, R.K.; Eyring, H. 1974: Pyrazolopyrimidine nucleosides. V. Methylation of the C-nucleoside antibiotic formycin and structural elucidation of products by magnetic circular dichroism spectroscopy. Journal of Organic Chemistry 39(14): 2023-2027

Gutowski, G.E.; Chaney, M.O.; Jones, N.D.; Hamill, R.L.; Davis, F.A.; Miller, R.D. 1973: Pyrazomycin B: isolation and characterization of an -C-nucleoside antibiotic related to pyrazomycin. Biochemical and Biophysical Research Communications 51(2): 312-317

Steen, S.N.; Ziment, I.; Thomas, J.S. 1974: Pyrbuterol: a new bronchodilator. Phase I-single dose study. Current Therapeutic Research 16(10): 1077-1081

Anonymous 1983: Pyrene. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans 32: 431-445

Edery, H. 1983: Pyrenebutyl-methylphosphonofluoridate: a fluorescent anti-cholinesterase in vivo. Archives of Toxicology. Supplement. 6: 327-332

Galla, H.J.; Hartmann, W. 1981: Pyrenedecanoic acid and pyrene lecithin. Methods in Enzymology 72: 471-479

Wolkowicz, P.E.; Pownall, H.J.; Pauly, D.F.; McMillin-Wood, J.B. 1984: Pyrenedodecanoylcarnitine and pyrenedodecanoyl coenzyme A: kinetics and thermodynamics of their intermembrane transfer. Biochemistry 23(26): 6426-6432

Okamoto, H.; Yoshida, D. 1980: Pyrenequinones as mutagens and enhancing agents to other mutagens. Mutation Research 73(1): 203-207

Vashkov, V.I.; Volkov, I.P.; Volkova, A.P.; Zubova, G.M.; Polishchuk, L.A.; Starkov, A.V.; Shenkman, I.A. 1966: Pyrethrins and related compounds. Insecticidal properties of allethrin. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 43(9): 114-117

Cole, L.M.; Ruzo, L.O.; Wood, E.J.; Casida, J.E. 1982: Pyrethroid metabolism: comparative fate in rats of tralomethrin, tralocythrin, deltamethrin, and (1R, alpha S)-cis-cypermethrin. Journal of Agricultural and Food Chemistry 30(4): 631-636

Poopathi, S.; Rao, D.R. 1995: Pyrethroid-impregnated hessian curtains for protection against mosquitoes indoors in south India. Medical and Veterinary Entomology 9(2): 169-175

Cagen, S.Z.; Malley, L.A.; Parker, C.M.; Gardiner, T.H.; Van Gelder, G.A.; Jud, V.A. 1984: Pyrethroid-mediated skin sensory stimulation characterized by a new behavioral paradigm. Toxicology and Applied Pharmacology 76(2): 270-279

Casida, J.E. 1980: Pyrethrum flowers and pyrethroid insecticides. Environmental Health Perspectives 34: 189-202

Wakhlu, A.K.; Peshin, S.N. 1969: Pyrethrum poisoning. Journal of the Indian Medical Association 52(3): 118

Olmos García de Alba, G.; Rodríguez García, A.; Valarezo Crespo, F. 1982: Pyretotherapy as a treatment in West syndrome. Boletin Medico del Hospital Infantil de Mexico 39(6): 445-449

Garcia de Alba, G.O.; Garćia, A.R.; Crespo, F.V. 1984: Pyretotherapy as treatment in West's syndrome. Clinical Eeg 15(3): 140-144

Ashford, R.F.; McLachlan, A.; Nelson, I.; Mughal, T.; Pickering, D. 1980: Pyrexia after cisplatin. Lancet 2(8196): 691-692

Waight, P.A.; Pollock, T.M.; Miller, E.; Coleman, E.M. 1983: Pyrexia after diphtheria/tetanus/pertussis and diphtheria/tetanus vaccines. Archives of Disease in Childhood 58(11): 921-923

Bowie, E.A. 1971: Pyrexia and dialysis. British Medical Journal 2(5752): 44-45

Chapman, R.S.; Mohamed, S.D. 1968: Pyrexia and elevated erythrocyte sedimentation rate in acute gastro-duodenal haemorrhage. Postgraduate Medical Journal 44(509): 238-241

Murphy, K.J. 1971: Pyrexia and raised serum-creatine-phosphokinase after amylobarbitone. Lancet 1(7702): 758-759

Machtey, I. 1968: Pyrexia following nialamide. Dapim Refuiim. Folia Medica 27(7): 279-280

De Villota, E.D.; Barat, G.; Astorqui, F.; Dámaso, D.; Avello, F. 1974: Pyrexia following open heart surgery. the role of bacterial infection. Anaesthesia 29(5): 529-536

Connor, B.H. 1970: Pyrexia in a rural Bantu children's ward. South African Medical Journal 44(16): 471-473

Marty, G. 1969: Pyrexia in postpartum revealing meningioma of the cerebellopontile angle. Bulletin de la Federation des Societes de Gynecologie et Dobstetrique de Langue Francaise 21(3): 271-273

Nakayama, A.; Suzuki, M.; Nishio, A. 1974: Pyrexia in rats desensitized to capsaicin. Nihon Seirigaku Zasshi. Journal of the Physiological Society of Japan 36(8-9): 393

Anonymous 1980: Pyrexia of dental origin. Lancet 1(8179): 1175

Anand, B.R. 1968: Pyrexia of uncertain origin in the Kashmir Valley: a preliminary study of one year. Indian Journal of Medical Sciences 22(10): 702-708

Shiach, C.R.; Burt, A.D.; Isles, C.G.; Ball, S.G. 1984: Pyrexia of undetermined origin, diarrhoea, and primary cerebral lymphoma associated with acquired immunodeficiency. British Medical Journal 288(6415): 449-450

Wong, S.Y.; Lam, M.S. 1995: Pyrexia of unknown origin--approach to management. Singapore Medical Journal 36(2): 204-208

Marilus, R.; Barkan, A.; Leiba, S.; Arie, R.; Blum, I. 1981: Pyrexia of unknown origin. Presenting sign of hypothalamic hypopituitarism. Postgraduate Medical Journal 57(667): 310-313

Hosang, R.; Bain, B.C.; Denbow, C.E. 1982: Pyrexia of unknown origin: a case of uterine leiomyosarcoma. British Journal of Obstetrics and Gynaecology 89(10): 864-866

Bray, R.S.; Ashford, R.W. 1971: Pyrexia treatment of diffuse cutaneous leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 65(1): 103

Rose, M.S.; Bateman, D.N. 1972: Pyrexia with cytosine arabinoside. British Medical Journal 4(5832): 115

Mehta, B.C. 1983: Pyrexia, abdominal pain and splenomegaly. Journal of the Association of Physicians of India 31(1): 45-46

Ishizuki, Y.; Hayami, S.; Kato, Y.; Isobe, K. 1967: Pyrexial mechanism in hyperthyroidism. Horumon to Rinsho. Clinical Endocrinology 15(4): 328-332

Robinson, P.J.; Rosen, S.M. 1971: Pyrexial reactions during haemodialysis. British Medical Journal 1(5748): 528-530

Begbie, I.V. 1972: Pyrford emergency box. Nursing Mirror and Midwives Journal 134(23): 39

Heinisch, G.; Mayrhofer, A. 1980: Pyridazine analogues of biologically active compounds, I: trans-4-Styrylpyridazines. Archiv der Pharmazie 313(1): 53-60

Leclerc, G.; Wermuth, C.G. 1971: Pyridazine derivatives of therapeutic interest. X. new syntheses from methyl-4-phenyl-6-pyridazone-3. Bulletin de la Societe Chimique de France (5): 1752-1756

Leclerc, G.; Wermuth, C.G. 1969: Pyridazine derivatives presenting a therapeutic interest. IX. Obtainment of cyclopropane derivatives by the action of alpha-haloesters on 3-pyridazones. Bulletin de la Societe Chimique de France (7): 2468-2470

Wermuth, C.G. 1965: Pyridazine derivatives presenting a therapeutic value. I. General review and personal contribution. Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 6(4): 383-398

Nitta, Y.; Matsuura, I.; Yoneda, F. 1965: Pyridazine derivatives. 8. Pyrido[2,3-d]pyridazines. i. Chemical and Pharmaceutical Bulletin 13(5): 586-593

Yoneda, F.; Nitta, Y.; Otaka, T. 1966: Pyridazine derivatives. IX. Syntheses of 2,3-diazaphenothiazine derivatives. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 86(10): 887-890

Yoneda, F.; Ohtaka, T.; Nitta, Y. 1965: Pyridazine derivatives. VII. Syntheses of 1,2- and 2,3-diazaphenothiazines. Chemical and Pharmaceutical Bulletin 13(5): 580-585

Yoneda, F.; Ohtaka, T.; Nitta, Y. 1966: Pyridazine derivatives. X. 10H-benzo[b]pyridazino[3,4-e][1,4]thiazine and 5H-benzo[b]pyridazino[4,3-e][1,4]thiazine. Chemical and Pharmaceutical Bulletin 14(7): 698-706

Yoneda, F.; Otaka, T. 1968: Pyridazine derivatives. XII. Synthesis of 3,4,-diazaphenothiazine derivatives. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 88(12): 1638-1641

Tori, K.; Ogata, M. 1964: Pyridazines. IX. Proton magnetic resonance studies of pyridazine, pyrazine, and substituted pyridazines. Chemical and Pharmaceutical Bulletin 12(3): 272-281

Zupan, M.; Stanovnik, B.; Tisler, M. 1972: Pyridazines. LI. Synthetic approaches to pyridazino(2,3-a)-1,3,5-triazines, a novel heterocyclic system. Journal of Organic Chemistry 37(19): 2960-2963

Petrovanu, M.; Caproşu, M.; Ungureanu, M.; Stavri, N. 1980: Pyridaziniums (XI). Effect of N-2',4',6'-trimethoxyphenacyl bromide on 3-phenylpyridazine. Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 84(3): 507-508; 514

Yamada, T.; Nobuhara, Y.; Yamaguchi, A.; Ohki, M. 1982: Pyridazinones. 1. Synthesis and antisecretory and antiulcer activities of thio amide derivatives. Journal of Medicinal Chemistry 25(8): 975-982

Yamada, T.; Nobuhara, Y.; Shimamura, H.; Tsukamoto, Y.; Yoshihara, K.; Yamaguchi, A.; Ohki, M. 1983: Pyridazinones. 2. Synthesis and antisecretory and antiulcer activities of thiourea and 2-cyanoguanidine derivatives. Journal of Medicinal Chemistry 26(3): 373-381

Yamada, T.; Shimamura, H.; Tsukamoto, Y.; Yamaguchi, A.; Ohki, M. 1983: Pyridazinones. 3. Synthesis, antisecretory, and antiulcer activities of 2-cyanoguanidine derivatives. Journal of Medicinal Chemistry 26(8): 1144-1149

Thaniyavarn, S.; Taylor, K.G.; Singh, S.; Doyle, R.J. 1982: Pyridine analogs inhibit the glucosyltransferase of Streptococcus mutans. Infection and Immunity 37(3): 1101-1111

Schultz, O.E.; Amschler, U.; Weber, H. 1972: Pyridine and quinoline analogues of procaine and procainamide. Arzneimittel-Forschung 22(7): 1117-1120

Rodig, O.R.; Collier, R.E.; Schlatzer, R.K. 1966: Pyridine chemistry. II. Further studies on the Smiles rearrangement of the 3-amino-2,2'-dipyridyl sulfide system. the synthesis of some 1,6-diazaphenothiazines. Journal of Medicinal Chemistry 9(1): 116-120

Singh, B.B.; Ormerod, M.G. 1966: Pyridine co-enzymes as electron scavengers in irradiated dry proteins. Biochemical and Biophysical Research Communications 25(1): 28-34

Pokotilenko, G.M. 1967: Pyridine coenzyme content of rat tissues in hyperthyreosis. Ukrains'kyi Biokhimichnyi Zhurnal 39(2): 215-219

Bistocchi, M.; D'Alessio, G. 1964: Pyridine coenzymes in spermatozoa. Bollettino della Societa Italiana di Biologia Sperimentale 40(24): 2054-2057

Araujo, M.da.S.; Cilento, G. 1969: Pyridine coenzymes. 8. Autoxidation of the reduced form catalyzed by 4-amino-2,6-diiodophenol. Biochemistry 8(5): 2145-2152

Schreier, S.; Cilento, G. 1969: Pyridine coenzymes. VII. Catalysis of the hydration of the reduced form by iodoaromatic compounds. Biochemistry 8(5): 2140-2145

Gnewuch, C.T.; Friedman, H.L. 1972: Pyridine isosteres of the -adrenergic antagonists, 2-(p-nitrophenyl)-1-isopropylamino-2-ethanol and 3-(p-nitrophenoxy)-1-isopropylamino-2-propanol. Journal of Medicinal Chemistry 15(12): 1321-1324

Nesnow, S.; Miyazaki, T.; Khwaja, T.; Meyer, R.B.; Heidelberger, C. 1973: Pyridine nucleosides related to 5-fluorouracil and thymine. Journal of Medicinal Chemistry 16(5): 524-528

Holmgren, A. 1980: Pyridine nucleotide - disulfide oxidoreductases. Experientia. Supplementum 36: 149-180

Su, G.; Wilson, J.E. 1971: Pyridine nucleotide binding sites of pig heart lipoyl dehydrogenase: fluorescence titrations. Archives of Biochemistry and Biophysics 143(1): 253-260

Powis, G.; Wincentsen, L. 1980: Pyridine nucleotide cofactor requirements of indicine N-oxide reduction by hepatic microsomal cytochrome P-450. Biochemical Pharmacology 29(3): 347-351

Korkach, V.I. 1974: Pyridine nucleotide concentrations in the muscles of rats following corticotropin and hydrocortisone administration. Biulleten' Eksperimental'noi Biologii i Meditsiny 78(9): 44-47

Zícha, B.; Benes, J. 1968: Pyridine nucleotide content in rat liver mitochondria after whole-body x-irradiation with 1400 R. Radiobiologia Radiotherapia 9(4): 501-508

Tabita, F.R. 1980: Pyridine nucleotide control and subunit structure of phosphoribulokinase from photosynthetic bacteria. Journal of Bacteriology 143(3): 1275-1280

Foster, J.W. 1981: Pyridine nucleotide cycle of Salmonella typhimurium: in vitro demonstration of nicotinamide adenine dinucleotide glycohydrolase, nicotinamide mononucleotide glycohydrolase, and nicotinamide adenine dinucleotide pyrophosphatase activities. Journal of Bacteriology 145(2): 1002-1009

Foster, J.W.; Baskowsky-Foster, A.M. 1980: Pyridine nucleotide cycle of Salmonella typhimurium: in vivo recycling of nicotinamide adenine dinucleotide. Journal of Bacteriology 142(3): 1032-1035

Ho, C.K.; Hashim, S.A. 1972: Pyridine nucleotide depletion in pancreatic islets associated with streptozotocin-induced diabetes. Diabetes 21(7): 789-793

McLaren, J.; Ngo, D.T.; Olivera, B.M. 1973: Pyridine nucleotide metabolism in Escherichia coli. 3. Biosynthesis from alternative precursors in vivo. Journal of Biological Chemistry 248(14): 5144-5149

Lundquist, R.; Olivera, B.M. 1971: Pyridine nucleotide metabolism in Escherichia coli. I. Exponential growth. Journal of Biological Chemistry 246(4): 1107-1116

Lundquist, R.; Olivera, B.M. 1973: Pyridine nucleotide metabolism in Escherichia coli. II. Niacin starvation. Journal of Biological Chemistry 248(14): 5137-5143

Manlapaz-Fernandez, P.; Olivera, B.M. 1973: Pyridine nucleotide metabolism in Escherichia coli. IV. Turnover. Journal of Biological Chemistry 248(14): 5150-5155

Kröger, I.; Werchau, H.; Kröger, H. 1966: Pyridine nucleotide metabolism in rat liver during carcinogenesis. Zeitschrift für Krebsforschung 68(2): 156-163

Yeh, Y.K.; Hankes, L.V.; Wessels, L.M. 1982: Pyridine nucleotide metabolism in the erythrocyte of South African blacks with primary hepatoma. Acta Vitaminologica et Enzymologica 4(3): 259-266

Findlay, G.H. 1966: Pyridine nucleotide micro-assay by the method of Slater and Sawyer. South African Medical Journal 40(40): 979-980

Nishiki, K.; Kobayashi, S. 1974: Pyridine nucleotide reduction in the liver induced by ethanol in vivo. Nihon Seirigaku Zasshi. Journal of the Physiological Society of Japan 36(8-9): 345

Erbland, J.F.; Marinetti, G.V.; Chatterjee, M. 1968: Pyridine nucleotide stimulation of lipid phosphorylation. Biochemical and Biophysical Research Communications 32(5): 745-751

Yamada, O.; Kiyohara, Y.; Sano, K.; Umezawa, C. 1983: Pyridine nucleotide synthesis in human blood--effect of leucine, alpha-ketoisocaproic acid and ketone bodies. International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift für Vitamin- und Ernahrungsforschung. Journal International de Vitaminologie et de Nutrition 53(4): 432-437

Lin, L.F.; Lan, S.J.; Richardson, A.H.; Henderson, L.M. 1972: Pyridine nucleotide synthesis. Purification of nicotinamide mononucleotide pyrophosphorylase from rat erythrocytes. Journal of Biological Chemistry 247(24): 8016-8022

Ragan, C.I.; Widger, W.R.; King, T.E. 1974: Pyridine nucleotide transhydrogenase activity of soluble cardiac NADH dehydrogenase and particulate NADH-ubiquinone reductase. Biochemical and Biophysical Research Communications 60(3): 894-900

Voordouw, G.; van der Vies, S.M.; Eweg, J.K.; Veeger, C.; van Breemen, J.F.; van Bruggen, E.F. 1980: Pyridine nucleotide transhydrogenase from Azotobacter vinelandii. Improved purification, physical properties and subunit arrangement in purified polymers. European Journal of Biochemistry 111(2): 347-355

Middleditch, L.E.; Atchison, R.W.; Chung, A.E. 1972: Pyridine nucleotide transhydrogenase from Azotobacter vinelandii. Some aspects of its structure. Journal of Biological Chemistry 247(21): 6802-6809

Evans, A.E.; Kaplan, N.O. 1966: Pyridine nucleotide transhydrogenase in normal human and leukemic leukocytes. Journal of Clinical Investigation 45(8): 1268-1272

Kaplan, N.O. 1971: Pyridine nucleotide transhydrogenases. Harvey Lectures 66: 105-133

DeChatelet, L.R.; Shirley, P.S. 1981: Pyridine nucleotide-dependent generation of hydrogen peroxide by a particulate fraction from human neutrophils. Journal of Immunology 126(3): 1165-1169

DeChatelet, L.R.; Shirley, P.S. 1982: Pyridine nucleotide-dependent generation of hydrogen peroxide by a particulate fraction from human neutrophils: effect of substrate concentration. Inflammation 6(3): 217-226

Pulich, W.M.; Van Baalen, C. 1973: Pyridine nucleotide-dependent glucose dehydrogenase activity in blue-green algae. Journal of Bacteriology 114(1): 28-33

Bannwarth, H.; Siebert, G. 1969: Pyridine nucleotides in Acetabularia mediterrranea before and after removel of the cell nucleus. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 350(11): 1475-1476

Falkson, H.C.; Falkson, G. 1965: Pyridine nucleotides in cancer. Lancet 2(7423): 1184-1185

Preuss, H.G. 1968: Pyridine nucleotides in renal ammonia metabolism. Journal of Laboratory and Clinical Medicine 72(3): 370-382

Ivanova, T.N.; Rubel', L.N. 1971: Pyridine nucleotides in the cerebral hemispheres of rats during hyperoxia. Doklady Akademii Nauk SSSR 196(1): 240-242

Oka, H.; Field, J.B. 1967: Pyridine nucleotides in the thyroid gland. 8. Effect of thyroid-stimulating hormone on nicotinic acid-14C incorporation into NAD, NADP and NADPH. Endocrinology 81(6): 1291-1296

Masters, B.R.; Riley, M.V.; Fischbarg, J.; Chance, B. 1983: Pyridine nucleotides of rabbit cornea with histotoxic anoxia: chemical analysis, non-invasive fluorometry and physiological correlates. Experimental Eye Research 37(1): 1-9

Butcher, F.R.; Serif, G.S. 1967: Pyridine nucleotides. 3. Response of dog thyroid pyridine nucleotides to hormonal control. Biochimica et Biophysica Acta 141(1): 8-18

Imai, T. 1971: Pyridine nucleotides. I. Nicotinamide mononucleotide deamidase and a new pathway for "salvage synthesis" of nicotinamide adenine dinucleotide. Seikagaku. Journal of Japanese Biochemical Society 43(6): 336-345

Imai, T.; Suzuki, S. 1971: Pyridine nucleotides. II. Isolation and identification of alpha-isomers of nicotinic acid mononucleotide and nicotinic acid-adenine dinucleotide. Seikagaku. Journal of Japanese Biochemical Society 43(6): 346-362

Chauhan, P.S.; Chauhan, C.K.; Chaudhury, S.K.; Datta, A.G. 1973: Pyridine nucleotides: basis for the hypotensive action of triphosphopyridine nucleotide. Indian Journal of Physiology and Pharmacology 17(4): 341-348

Chauhan, P.S. 1969: Pyridine nucleotides: nicotinamide adenine dinucleotide and the cholinergic mechanisms. Indian Journal of Medical Research 57(2): 301-305

Demarco, P.V. 1969: Pyridine solvent shifts in the NMR analysis of etythromycin aglycones. Tetrahedron Letters 5: 383-386

Franz, M. 1969: Pyridine-2,4,6-tricarboxylic acid synthesis and analytical use. Journal de Pharmacie de Belgique 24(7): 357-364

Kimura, K. 1974: Pyridine-2,6-dicarboxylic acid (dipicolinic acid) formation in Bacillus subtilis. I. Non-enzymatic formation of dipicolinic acid from pyruvate and aspartic semialdehyde. Journal of Biochemistry 75(5): 961-967

Foks, H.; Sawlewicz, J. 1973: Pyridine-3-carbothioamide reaction with methyl iodide in alkaline medium. Acta Poloniae Pharmaceutica 30(2): 149-153

Arch, F. 1967: Pyridine-4-carboxylic acid-(dexamethasone-21')-ester in aerosol dosage. Medizinische Klinik 62(31): 1202-1205

De Luca, C.; Gioeli, R.P. 1972: Pyridine-adenine dinucleotide transhydrogenase activity in cells cultured from rat hepatoma. Canadian Journal of Biochemistry 50(5): 447-456

Piastunovich, K.A.; Brilliantova, S.A. 1980: Pyridine-dependent dehydrogenase activity in the blood serum and erythrocytes during gynecologic operations performed under different types of anesthesia. Akusherstvo i Ginekologiia 6: 32-35

Uroshleva, L.A.; Aksenova, T.A.; Brilliantova, S.A. 1983: Pyridine-dependent dehydrogenase activity in the erythrocytes in physiological and complicated pregnancy. Akusherstvo i Ginekologiia 6: 33-35

Bistocchi, M.; D'Alessio, G.; Leone, E. 1968: Pyridine-nucleotide coenzymes in bull and rabbit spermatozoa. Journal of Reproduction and Fertility 16(2): 223-231

Bellomo, G.; Martino, A.; Richelmi, P.; Moore, G.A.; Jewell, S.A.; Orrenius, S. 1984: Pyridine-nucleotide oxidation, Ca2+ cycling and membrane damage during tert-butyl hydroperoxide metabolism by rat-liver mitochondria. European Journal of Biochemistry 140(1): 1-6

Van den Broek, W.J.; Santema, J.S.; Wassink, J.H.; Veeger, C. 1971: Pyridine-nucleotide transhydrogenase. 1. Isolation, purification and characterisation of the transhydrogenase from Azotobacter vinelandii. European Journal of Biochemistry 24(1): 31-45

Van den Broek, W.J.; Van Breemen, J.F.; Van Bruggen, E.F.; Veeger, C. 1971: Pyridine-nucleotide transhydrogenase. 2. Electron-microscopic studies on the transhydrogenase from Azotobacter vinelandii. European Journal of Biochemistry 24(1): 46-54

Van den Broek, W.J.; Santema, J.S.; Veeger, C. 1971: Pyridine-nucleotide transhydrogenase. 3. Effect of NADP+ on the spectral properties of transhydrogenase from Azotobacter vinelandii. European Journal of Biochemistry 24(1): 55-62

Van den Broek, W.J.; Veeger, C. 1971: Pyridine-nucleotide transhydrogenase. 4. Studies on the reductive mechanism of transhydrogenase from Azotobacter vinelandii. European Journal of Biochemistry 24(1): 63-71

Van den Broek, W.J.; Veeger, C. 1971: Pyridine-nucleotide transhydrogenase. 5. Kinetic studies on transhydrogenase from Azotobacter vinelandii. European Journal of Biochemistry 24(1): 72-82

Barlam, T.; Neu, H.C. 1984: Pyridinium 2-azo-p-dimethylaniline chromophore, a chromogenic reagent for beta-lactamase testing compared to nitrocefin. European Journal of Clinical Microbiology 3(3): 185-189

Oldiges, H.; Schoene, K. 1970: Pyridinium and imidazolium salts as antidotes for soman and paraoxon poisoning in mice. Archiv für Toxikologie 26(4): 293-305

Schoene, K. 1980: Pyridinium salts as organophosphate antagonists. Monographs in Neural Sciences 7: 85-98

Jorgensen, J.H.; Crawford, S.A.; Alexander, G.A. 1982: Pyridinium-2-azo-p-dimethylaniline chromophore, a new chromogenic cephalosporin for rapid beta-lactamase testing. Antimicrobial Agents and ChemoTherapy 22(1): 162-164

Sanwald, R. 1972: Pyridinol carbamate in atherosclerosis. Deutsche Medizinische Wochenschrift 97(14): 583-584

Etchevés, J.C.; Buzzi, R.M.; Bruno, E.; Sacanell, C. 1968: Pyridinol carbamate, a new approach in the prevention and therapy of atherosclerosis. Hospital 74(3): 807-814

Takeda, H.; Hisamichi, K.; Fujita, H.; Muroga, S.; Suzuki, S. 1983: Pyridinol derivatives (4). Synthesis and pharmacological actions of 3,4-dihydro-2H-pyrido[3,2-b]-1,4-oxazine derivatives. (1). Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 103(5): 497-507

Takeda, H.; Fujita, H.; Muroga, S.; Suzuki, S.; Hisamichi, K. 1983: Pyridinol derivatives. (6) Synthesis and pharmacological activity of 4-(2-dialkylamino-1-phenylethyl)-2H-pyrido[3,2-b]-1,4-oxazin-3-one derivatives. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 103(8): 825-834

Takeda, H.; Muroga, S.; Fujita, H.; Hisamichi, K.; Suzuki, S. 1983: Pyridinol derivatives. (7) Synthesis and pharmacological activity of 4-(2-dialkylamino-1-phenylethyl)-3,4-dihydro-2H-pyrido[3,2-b]-1,4-oxazine derivatives. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 103(8): 835-848

Takeda, H.; Fujita, H.; Muroga, S.; Suzuki, S.; Hisamichi, K. 1983: Pyridinol derivatives. (8) Synthesis and pharmacological activity of 4-phenylalkyl-2H-pyrido[3,2-b]-1,4-oxazin-3-one derivatives. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 103(8): 849-856

Takeda, H.; Muroga, S.; Fujita, H.; Hisamichi, K.; Suzuki, S. 1983: Pyridinol derivatives. (9) Synthesis and pharmacological activity of 4-phenylalkyl-3,4-dihydro-2H-pyrido[3,2-b]-1,4-oxazine derivatives. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 103(8): 857-866

de Oliveira, J.M. 1968: Pyridinol-carbamate and atherosclerosis. Clinical observations and animal experimentation. Hospital (Rio de Janeiro) 74(3): 799-806

Tirkina, T.N.; Aleksandrova, L.M.; Kliachko, V.R.; Mazovetskiĭ, A.G. 1974: Pyridinolcarbamate (anginin) in the treatment of diabetic angiopathies. Terapevticheskii Arkhiv 46(1): 107-110

Damas, J.; Lallemand, G. 1974: Pyridinolcarbamate and bradykinin in the rat. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 168(2-3): 379-382

Spina, A. 1972: Pyridinolcarbamate in the therapy of hemicrania syndromes. Acta Neurologica 27(6): 610-617

Guzman, S.V. 1972: Pyridinolcarbamate in the treatment of ischemic heart diseases. a double blind study. Japanese Heart Journal 13(1): 53-58

Parodi, F.A. 1974: Pyridinolcarbamate in the treatment of peripheral vascular diseases in diabetics. Observations after 3 years of clinical use. Minerva Medica 65(40): 2316-2320

Motomiya, T. 1970: Pyridinolcarbamate treatment of atherosclerosis obliterans analysed by toe plethysmography. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 59(2): 117-125

Shimamoto, T.; Maezawa, H.; Yamazaki, H.; Atsumi, T.; Fujita, T.; Ishioka, T.; Sunaga, T. 1966: Pyridinolcarbamate, a bradykinin antagonist in veins. A preliminary report on pharmacologic and clinical observations. American Heart Journal 71(3): 297-312

Shimamoto, T.; Atsumi, T. 1965: Pyridinolcarbamate, bradykinin antagonist, in patients suffering from arteriosclerosis obliterans and thromboangiitis obliterans (Buerger's disease); a preliminary report on the treatment of human atherosclerosis. Japanese Heart Journal 6(5): 407-415

Saari, W.S.; Halczenko, W.; King, S.W.; Huff, J.R.; Guare, J.P.; Hunt, C.A.; Randall, W.C.; Anderson, P.S.; Lotti, V.J.; Taylor, D.A. 1983: Pyridinylpiperazines, a new class of selective alpha 2-adrenoceptor antagonists. Journal of Medicinal Chemistry 26(12): 1696-1701

Rizkalla, B.H.; Broom, A.D.; Stout, M.G.; Robins, R.K. 1972: Pyrido (2,3-d) pyrimidines. II. Synthesis of ribonucleosides of 4-oxo- and 2,4-dioxopyrido (2,3-d) pyrimidines. Journal of Organic Chemistry 37(25): 3975-3979

Israel, M.; Tirosh, N. 1973: Pyrido (3,2-g)pteridines. 2. Synthesis and growth-inhibitory evaluation of some 10-substituted 3H, 10H-2,4-dioxopyrido(3,2-g)pteridines (9-azaisoalloxazines). Journal of Medicinal Chemistry 16(5): 520-524

Sawyer, J.R.; Wibberley, D.G. 1973: Pyrido(1,2-a)pyrimidinium salts. I. Synthesis from 2-aminopyridines and interconversion with 2-(2-acylvinylamino)pyridines. Journal of the Chemical Society. Perkin Transactions 1 11: 1138-1143

Matsumoto, J.; Minamida, A.; Minami, S. 1980: Pyrido(2,3-d)pyrimidine antibacterial agents. V. Synthesis and reactions of 1H,5H-imidazo(1,2-a)pyrido(2,3-d)pyrimidines. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 100(12): 1187-1193

Santilli, A.A.; Kim, D.H. 1972: Pyrido(2,3-d)pyrimidine-6-carboxamides as potential diuretic agents. Journal of Medicinal Chemistry 15(4): 442-443

Rizkalla, B.H.; Broom, A.D. 1972: Pyrido(2,3-d)pyrimidines. 3. Synthesis of some 8-( -D-ribofuranosyl)pyrido(2,3-d)pyrimidines structurally related to the antibiotic sangivamycin. Journal of Organic Chemistry 37(25): 3980-3985

Görlitzer, K.; Wilpert, C.; Rübsamen-Waigmann, H.; Suhartono, H.; Wang, L.; Immelmann, A. 1995: Pyrido(3,2-e)(1,4)diazepines--synthesis and testing of anti-HIV-1 activity. Archiv der Pharmazie 328(3): 247-255

Israel, M.; Jones, L.C.; Modest, E.J. 1972: Pyrido(3,2-g)pteridines. 1. Chemistry and growth-inhibitory activity of some 1H,3H-2,4-dioxopyrido(3,2-g)pteridines (9-azaalloxazines). Journal of Medicinal Chemistry 15(5): 559-561

Tilley, J.W.; LeMahieu, R.A.; Carson, M.; Kierstead, R.W.; Baruth, H.W.; Yaremko, B. 1980: Pyrido[2,1-b]quinazolinecarboxylic acids as orally active antiallergy agents. Journal of Medicinal Chemistry 23(1): 92-95

Minami, S.; Shono, T.; Matsumoto, J. 1971: Pyrido[2,3-d]pyrimidine antibacterial agents. I. 8-alkyl-5,8-dihydro-5-oxopyrido[2,3-d]-pyrimidine-6-carboxylic acids and related compounds. Chemical and Pharmaceutical Bulletin 19(7): 1482-1486

Matsumoto, J.; Minamida, A.; Kimura, Y.; Minami, S. 1980: Pyrido[2,3-d]pyrimidine antibacterial agents. IV. Synthesis of metabolites of piromidic acid. Chemical and Pharmaceutical Bulletin 28(8): 2531-2536

Youssefyeh, R.D.; Brown, R.E.; Wilson, J.; Shah, U.; Jones, H.; Loev, B.; Khandwala, A.; Leibowitz, M.J.; Sonnino-Goldman, P. 1984: Pyrido[3',2':4,5]thieno[3,2-d]-N-triazines: a new series of orally active antiallergic agents. Journal of Medicinal Chemistry 27(12): 1639-1643

Hirose, T.; Mishio, S.; Matsumoto, J.; Minami, S. 1982: Pyridone-carboxylic acids as antibacterial agents. I. Synthesis and antibacterial activity of 1-alkyl-1,4-dihydro-4-oxo-1,8- and 1,6-naphthyridine-3-carboxylic acids. Chemical and Pharmaceutical Bulletin 30(7): 2399-2409

Matsumoto, J.; Miyamoto, T.; Minamida, A.; Nishimura, Y.; Egawa, H.; Nishimura, H. 1984: Pyridonecarboxylic acids as antibacterial agents. 2. Synthesis and structure-activity relationships of 1,6,7-trisubstituted 1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acids, including enoxacin, a new antibacterial agent. Journal of Medicinal Chemistry 27(3): 292-301

Egawa, H.; Miyamoto, T.; Minamida, A.; Nishimura, Y.; Okada, H.; Uno, H.; Matsumoto, J. 1984: Pyridonecarboxylic acids as antibacterial agents. 4. Synthesis and antibacterial activity of 7-(3-amino-1-pyrrolidinyl)-1-ethyl-6-fluoro-1,4 -dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid and its analogues. Journal of Medicinal Chemistry 27(12): 1543-1548

Todo, Y.; Takagi, H.; Iino, F.; Fukuoka, Y.; Takahata, M.; Okamoto, S.; Saikawa, I.; Narita, H. 1994: Pyridonecarboxylic acids as antibacterial agents. IX. Synthesis and structure-activity relationship of 3-substituted 10-(1-aminocyclopropyl)-9-fluoro-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]- 1,4-benzoxazine-6-carboxylic acids and their 1-thio and 1-aza analogues. Chemical and Pharmaceutical Bulletin 42(12): 2569-2574

Mishio, S.; Hirose, T.; Minamida, A.; Matsumoto, J.; Minami, S. 1985: Pyridonecarboxylic acids as antibacterial agents. V. Synthesis of 1-vinyl-1,4-dihydro-4-oxo-1,8- and 1,6-naphthyridine-3-carboxylic acids. Chemical and Pharmaceutical Bulletin 33(10): 4402-4408

Todo, Y.; Nitta, J.; Miyajima, M.; Fukuoka, Y.; Ikeda, Y.; Yamashiro, Y.; Saikawa, I.; Narita, H. 1994: Pyridonecarboxylic acids as antibacterial agents. VII. Synthesis and structure-activity relationship of amino- and hydroxyl-substituted 7-cycloalkyl and 7-vinyl derivatives of 1-cyclopropyl-6-fluoro-4-quinolone-3- carboxylic acid. Chemical and Pharmaceutical Bulletin 42(10): 2055-2062

Hwang, D.R.; Proctor, G.R.; Driscoll, J.S. 1980: Pyridones as potential antitumor agents II: 4-Pyridones and bioisosteres of 3-acetoxy-2-pyridone. Journal of Pharmaceutical Sciences 69(9): 1074-1076

Nivet, M.; Delamare, J.; Roure, H. 1966: Pyridophyllin in cardiovascular and respiratory therapeutics. Gazette Medicale de France 73(4): 805-812

Glazer, E.A.; Presslitz, J.E. 1982: Pyridoquinoxaline N-oxides. 2. Synthesis and antibacterial activity of tricyclic lactams. Journal of Medicinal Chemistry 25(7): 868-870

Dörner, G.; Tönjes, R.; Hecht, K.; Hinz, G.; Poppe, I.; Poppei, M.; Tsamaloukas, A. 1981: Pyridostigmine administration in newborn rats prevents permanent mental ill-effects produced by maternal deprivation. Endokrinologie 77(1): 101-104

Sadjadpour, K. 1983: Pyridostigmine bromide and constipation in Parkinson's disease. JAMA 249(9): 1148

Roberts, D.E.; Sawka, M.N.; Young, A.J.; Freund, B.J. 1994: Pyridostigmine bromide does not alter thermoregulation during exercise in cold air. Canadian Journal of Physiology and Pharmacology 72(7): 788-793

Somani, S.M.; Roberts, J.B.; Wilson, A. 1972: Pyridostigmine metabolism in man. Clinical Pharmacology and Therapeutics 13(3): 393-399

Barber, H.E.; Bourne, G.R. 1973: Pyridostigmine pharmacokinetics: evidence for an apparent capacity limited urinary elimination of the metabolites of pyridostigmine. British Journal of Pharmacology 48(2): 329P-330P

Zawisza, T.; Respond, S. 1973: Pyridothiazines. I. Synthesis of 3H-2-imino-4-oxopyrido-(2,3-e)(1,3)thiazine and 3H-2,4-dioxopyrido(2,3-e)(1,3)thiazine. Polish Journal of Pharmacology and Pharmacy 25(4): 385-390

Szajnert, M.F.; Beck, G.; Schapira, F. 1983: Pyridoxal 5' phosphate involvement in age-related modifications of tyrosine aminotransferase: multiple form patterns. Biochimie 65(2): 135-141

Rippa, M.; Pontremoli, S. 1969: Pyridoxal 5'-phosphate as a specific photosensitizer for histidine residue at the active site of 6-phosphogluconate dehydrogenase. Archives of Biochemistry and Biophysics 133(1): 112-118

Lacour, B.; Parry, C.; Drüeke, T.; Touam, M.; Kreis, H.; Bailly, M.; Durand, D. 1983: Pyridoxal 5'-phosphate deficiency in uremic undialyzed, hemodialyzed, and non-uremic kidney transplant patients. Clinica Chimica Acta; International Journal of Clinical Chemistry 127(2): 205-215

Middleton, H.M. 1983: Pyridoxal 5'-phosphate disappearance from perfused rat jejunal segments: correlation with perfusate alkaline phosphatase and water absorption. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 174(2): 249-257

Håkanson, R. 1967: Pyridoxal 5'-phosphate enzymes. Influence of substrate concentration on the pH optimum of enzyme reactions involving transaldimination. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 348(12): 1730-1733

Kamogawa, A. 1969: Pyridoxal 5'-phosphate in alpha-glucan phosphorylase from the potato. Biochimica et Biophysica Acta 178(3): 459-469

Sloger, M.S.; Reynolds, R.D. 1981: Pyridoxal 5'-phosphate in whole blood, plasma and blood cells of postpartum nonlactating and lactating rats and their pups. Journal of Nutrition 111(5): 823-830

Glazer, R.I.; Weber, G. 1971: Pyridoxal 5'-phosphate inhibition of lactate production in rat liver supernatant fluid. Biochimica et Biophysica Acta 237(1): 11-13

Wilson, P.D.; Smith, G.P.; Peters, T.J. 1983: Pyridoxal 5'-phosphate: a possible physiological substrate for alkaline phosphatase in human neutrophils. Histochemical Journal 15(3): 257-264

Ninh, N.V.; Arányi, P.; Horváth, I. 1982: Pyridoxal 5-phosphate protection of trypsin cleavage site on the glucocorticoid receptor protein. Journal of Steroid Biochemistry 17(6): 599-601

Matsushima, Y.; Martell, A.E. 1967: Pyridoxal analogs. IX. Electron absorption spectra and molecular species in methanol solution. Journal of the American Chemical Society 89(6): 1322-1330

Davis, R.E.; Smith, B.K. 1974: Pyridoxal and folate deficiency in alcoholics. Medical Journal of Australia 2(10): 357-360

Pikulev, A.T.; Khripchenko, I.P.; Shumilina, T.A. 1981: Pyridoxal coenzyme content in the tissues of irradiated animals as affected by adrenoblockaders in in vitro experiments. Radiobiologiia 21(5): 772-776

Podorozhnyĭ, P.G.; Tomashevskiĭ, I.I. 1972: Pyridoxal coenzymes in the blood plasma in patients with rheumatism. Vrachebnoe Delo 1: 44-46

Williams, A.; Hoy, T.; Pugh, A.; Jacobs, A. 1982: Pyridoxal complexes as potential chelating agents for oral therapy in transfusional iron overload. Journal of Pharmacy and Pharmacology 34(11): 730-732

Benesch, R.E.; Yung, S.; Suzuki, T.; Bauer, C.; Benesch, R. 1973: Pyridoxal compounds as specific reagents for the alpha and beta N-termini of hemoglobin. Proceedings of the National Academy of Sciences of the United States of America 70(9): 2595-2599

Morino, Y. 1968: Pyridoxal enzymes, with special reference to aspartate aminotransferase and tryptophanase. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 13(6): 574-585

Loo, Y.H.; Whittaker, V.P. 1967: Pyridoxal kinase in brain and its inhibition by pyridoxylidene-beta-phenylethylamine. Journal of Neurochemistry 14(10): 997-1011

Contractor, S.F.; Shane, B. 1969: Pyridoxal kinase in the human placenta and foetus through gestation. Clinica Chimica Acta; International Journal of Clinical Chemistry 25(3): 465-474

Jung, K.; Ohlrich, B.; Mildner, D.; Scholz, D. 1981: Pyridoxal phosphate activation of aminotransferases in serum of patients with kidney transplants. Clinical Chemistry 27(1): 205-206

Pérez de la Mora, M.; Feria-Velasco, A.; Tapia, R. 1973: Pyridoxal phosphate and glutamate decarboxylase in subcellular particles of mouse brain and their relationship to convulsions. Journal of Neurochemistry 20(6): 1575-1587

Cheung, T.; Briggs, M.H. 1974: Pyridoxal phosphate and the measurement of aminotransferase activity. Clinica Chimica Acta; International Journal of Clinical Chemistry 54(1): 127-129

Bhagwat, A.S.; McFadden, B.A. 1983: Pyridoxal phosphate as a probe in the active site of ribulose bisphosphate carboxylase/oxygenase. Archives of Biochemistry and Biophysics 223(2): 610-617

Kark, J.A.; Tarassoff, P.G.; Bongiovanni, R. 1983: Pyridoxal phosphate as an antisickling agent in vitro. Journal of Clinical Investigation 71(5): 1224-1229

Cidlowski, J.A.; Currie, R.A. 1982: Pyridoxal phosphate blocks aggregation of molybdate treated glucocorticoid receptors in Hela S3 cells. Journal of Steroid Biochemistry 17(3): 277-280

De Marco, C.; Rinaldi, A.; Fadda, M.B. 1973: Pyridoxal phosphate catalyzed alpha-beta elimination of S-gamma-aminopropylcysteine. Physiological Chemistry and Physics 5(6): 463-467

Ejderhamn, J.; Hamfelt, A. 1980: Pyridoxal phosphate concentration in blood in newborn infants and their mothers compared with the amount of extra pyridoxol taken during pregnancy and breast feeding. Acta Paediatrica Scandinavica 69(3): 327-330

Hamfelt, A.; Hahn, L. 1969: Pyridoxal phosphate concentration in plasma and tryptophan load test during pregnancy. Clinica Chimica Acta; International Journal of Clinical Chemistry 25(1): 91-96

Hamfelt, A.; Wetterberg, L. 1969: Pyridoxal phosphate in acute intermittent porphyria. Annals of the new York Academy of Sciences 166(1): 361-364

Atanasov, B.P.; Mitovska, M.I.; Mancheva, I.N.; Kossekova, G.P.; Tchorbanov, B.P.; Christova, P.; Dancheva, K.I. 1984: Pyridoxal phosphate modified cytochromes c. Identification and electron transfer properties. Biochimica et Biophysica Acta 765(3): 329-339

Morino, Y.; Nagashima, F. 1984: Pyridoxal phosphate-binding site in enzymes; reduction and comparison of sequences. Methods in Enzymology 106: 116-137

Cozzani, I.; Santoni, C.; Jori, G.; Gennari, G.; Tamburro, A.M. 1974: Pyridoxal phosphate-sensitized photoinactivation of glutamate decarboxylase from Clostridium perfringens. Biochemical Journal 141(2): 463-468

Hullar, T.L.; French, W.C. 1969: Pyridoxal phosphate. 3. Pyrimidine analogs. 3-(Substituted 5-pyrimidyl)propionic acids as potential inhibitory analogs of pyridoxal phosphate. Journal of Medicinal Chemistry 12(3): 424-426

Hullar, T.L. 1969: Pyridoxal phosphate. I. Phosphonic acid analogs of pyridoxal phosphate. Synthesis via Wittig reactions and enzymic evaluation. Journal of Medicinal Chemistry 12(1): 58-63

Hullar, T.L.; Failla, D.L. 1969: Pyridoxal phosphate. II. Benzene analogs. 2-Formylphenoxyacetic acids as potential antimetabolites of pyridoxal phosphate. Journal of Medicinal Chemistry 12(3): 420-424

Davis, R.E.; Smith, B.K. 1974: Pyridoxal, vitamin B12 and folate metabolism in women taking oral contraceptive agents. South African Medical Journal 48(46): 1937-1940

Shin, Y.S.; Rasshofer, R.; Endres, W. 1984: Pyridoxal-5'-phosphate concentration as marker for vitamin-B6-dependent seizures in the newborn. Lancet 2(8407): 870-871

Black, I.B. 1971: Pyridoxal-5'-phosphate--an inhibitor of catechol-O-methyltransferase in vitro. Biochemical Pharmacology 20(4): 924-927

Hollaar, L.; Jansen, P.Y.; van der Laarse, A.; Dijkshoorn, N.J.; Bogers, A.J.; Huysmans, H.A. 1984: Pyridoxal-5'-phosphate-induced stimulation of aspartate aminotransferase and its isoenzymes in human myocardial biopsies and autopsies. Clinica Chimica Acta; International Journal of Clinical Chemistry 139(1): 47-53

Náray, A.; Báthori, G. 1982: Pyridoxal-5-phosphate affects glucocorticoid receptors in intact lymphocytes similarly as in cell-free systems. Journal of Steroid Biochemistry 16(2): 199-205

Zaveniagina, T.N.; Bukin, I.V. 1971: Pyridoxal-5-phosphate content of wheat and pea seeds and seedlings. Biokhimiia 36(1): 205-215

Vibrans, U.; Hilgenfeldt, J.; Petres, J. 1972: Pyridoxal-5-phosphate in porphyria cutanea tarda. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 23(4): 155-160

Bhagavan, H.N.; Coleman, M.; Coursin, D.B.; Rosenfeld, P. 1973: Pyridoxal-5-phosphate levels in whole blood in home-reared patients with trisomy 21. Lancet 1(7808): 889-890

Guirard, B.M.; Tanase, S.; Snell, E.E. 1984: Pyridoxal-P dependent bacterial histidine decarboxylase. Progress in Clinical and Biological Research 144a: 235-244

Rippa, M.; Ronchi, S.; Minchiotti, L. 1974: Pyridoxal-phosphate-binding sites of 6-phosphogluconate dehydrogenase. Italian Journal of Biochemistry 23(4): 272-273

Atanasov, B.P.; Kosekova, G.P.; Mitovska, M.I.; Khristova, P.K.; Dancheva, K.I. 1980: Pyridoxalphosphate-modified derivatives of cytochrome c. Mono- and disubstituted derivatives: characteristics and effect on electron transport in cytochrome c-depleted mitochondria. Molekuliarnaia Biologiia 14(2): 307-315

Yagi, T.; Kagamiyama, H.; Nozaki, M. 1982: Pyridoxamine-alpha-keto acid transamination activity of aspartate apoaminotransferases. Biochemical and Biophysical Research Communications 107(3): 897-902

Schmidt, E. 1968: Pyridoxin requirements in the pyretic newborn and infants. Monatsschrift für Kinderheilkunde 116(6): 277

Frimpter, G.W. 1968: Pyridoxine (B6) dependency syndromes. Annals of Internal Medicine 68(5): 1131-1132

Anonymous 1980: Pyridoxine (pyridoxamine) 5'-phosphate oxidase in human red cells. Nutrition Reviews 38(11): 380-381

Clements, J.E.; Anderson, B.B. 1980: Pyridoxine (pyridoxamine) phosphate oxidase activity in the red cell. Biochimica et Biophysica Acta 613(2): 401-409

Naess, K. 1970: Pyridoxine (vitamin B6) in isoniazid treatment. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 90(3): 323-324

Braginskii, B.M.; Artaeva, L.P. 1973: Pyridoxine adequacy in atherosclerotic cardiosclerosis and hypertension. Kardiologiia 13(5): 25-29

Beutler, E.; Paniker, N.V.; West, C.J. 1972: Pyridoxine administration in sickle cell disease: an unsuccessful attempt to influence the properties of sickle hemoglobin. Biochemical Medicine 6(2): 139-143

Kaufmann, G. 1984: Pyridoxine against amiodarone-induced photosensitivity. Lancet 1(8367): 51-52

Jaffe, I.A. 1970: Pyridoxine and anergy in Hodgkin's disease. New England Journal of Medicine 282(23): 1326

Davis, R.E.; Smith, B.K. 1973: Pyridoxine and depression associated with oral contraception. Lancet 1(7814): 1245

Casacchia, M.; Boni, B.; Meco, G. 1982: Pyridoxine and depression: neuroendocrine aspects. Acta Vitaminologica et Enzymologica 4(1-2): 55-58

McCann, V.J.; Davis, R.E. 1983: Pyridoxine and diabetic neuropathy: a double-blind controlled study. Diabetes Care 6(1): 102-103

Nagai, K.; Nakai, K. 1970: Pyridoxine and erythropoiesis. Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 33(2): 191-192

Yahr, M.D.; Duvoisin, R.C. 1972: Pyridoxine and levodopa in the treatment of Parkinsonism. JAMA 220(6): 861

French, J.H. 1969: Pyridoxine and myoclonic seizures. Annals of the new York Academy of Sciences 166(1): 310-313

Luhby, A.L.; Davis, P.; Murphy, M.; Gordon, M.; Brin, M.; Spiegel, H. 1970: Pyridoxine and oral contraceptives. Lancet 2(7682): 1083

Azar, A.; Thomas, A.A.; Shillito, F.H. 1970: Pyridoxine and phenobarbital as treatment for aerozine-50 toxicity. Aerospace Medicine 41(1): 1-4

Stokes, J.; Mendels, J. 1972: Pyridoxine and premenstrual tension. Lancet 1(7761): 1177-1178

Abbott, E.H.; Martell, A.E. 1970: Pyridoxine and pyridoxal analogs. 13. a nuclear magnetic resonance study of the condensation of polyfunctional amino acids with pyridoxal. Journal of the American Chemical Society 92(6): 1754-1759

Bucci, L. 1973: Pyridoxine and schizophrenia. British Journal of Psychiatry: the Journal of Mental Science 122(567): 240

Leon, A.S.; Spiegel, H.E.; Thomas, G.; Abrams, W.B. 1971: Pyridoxine antagonism of levodopa in parkinsonism. JAMA 218(13): 1924-1927

Korytnyk, W.; Fricke, G.; Paul, B. 1966: Pyridoxine chemistry. XII. Gas chromatography of compounds in the vitamin B6 group. Analytical Biochemistry 17(1): 66-75

Ahrens, H.; Korytnyk, W. 1969: Pyridoxine chemistry. XXI. Thin-layer chromatography and thin-layer electrophoresis of compounds in the vitamin B6 group. Analytical Biochemistry 30(3): 413-420

Lasitsa, O.I. 1967: Pyridoxine content in different forms of milk and kefir. Pediatriia Akusherstvo i Ginekologiia 1: 23-24

Rothschild, B. 1982: Pyridoxine deficiency. Archives of Internal Medicine 142(4): 840

Anonymous 1967: Pyridoxine deficiency and acute porphyria. Nutrition Reviews 25(1): 7-8

Tews, J.K. 1969: Pyridoxine deficiency and brain amino acids. Annals of the new York Academy of Sciences 166(1): 74-82

Morris, J.S.; Ajdukiewicz, A.B.; Read, A.E. 1969: Pyridoxine deficiency in celiac disease and the detection of neuropsychiatric disorders. Gut 10(12): 1057

Demers, R.G.; McDonagh, P.H.; Moore, R.J. 1984: Pyridoxine deficiency with phenelzine. Southern Medical Journal 77(5): 641-642

Schlesinger, K.; Uphouse, L.L. 1972: Pyridoxine dependency and central nervous system excitability. Advances in Biochemical Psychopharmacology 4: 105-140

Swaiman, K.F.; Milstein, J.M. 1970: Pyridoxine dependency and penicillamine. Neurology 20(1): 78-81

Iinuma, K.; Narisawa, K.; Yamauchi, N.; Yoshida, T.; Mizuno, T. 1971: Pyridoxine dependent convulsion: effect of pyridoxine therapy on electroencephalograms. Tohoku Journal of Experimental Medicine 105(1): 19-26

Bankier, A.; Turner, M.; Hopkins, I.J. 1983: Pyridoxine dependent seizures--a wider clinical spectrum. Archives of Disease in Childhood 58(6): 415-418

Jameson, H.D. 1970: Pyridoxine for levodopa-induced dystonia. JAMA 211(10): 1700

Tokunaga, H.; Kimura, T.; Kawamura, J. 1982: Pyridoxine hydrochloride reference standard (Control 801) of National Institute of Hygienic Sciences. Eisei Shikenjo hokoku. Bulletin of National Institute of Hygienic Sciences 1982(100): 184-185

Hagberg, B.; Hambraeus, L.; Hamfelt, A. 1969: Pyridoxine in homocystinuria. Lancet 2(7614): 271

Gupta, A.P.; Gupta, A.; Goyal, V.; Agarwal, S. 1984: Pyridoxine in tetanus neonatorum. Indian Pediatrics 21(4): 345

Cohen, A.C. 1969: Pyridoxine in the prevention and treatment of convulsions and neurotoxicity due to cycloserine. Annals of the new York Academy of Sciences 166(1): 346-349

Than, N.; Kóbor, J.; Tóth, E. 1969: Pyridoxine in the treatment of early pregnancy toxemia. I. Change of gastric secretion under the effect of vitamin B 6 controlled by Acidotest. Zeitschrift für Geburtshilfe und Gynakologie 170(1): 77-82

Than, N.; Kóbor, J.; Tóth, E. 1969: Pyridoxine in the treatment of early pregnancy toxemias. II. Theoretical contribution to the mechanism of action of vitamin B 6. Zeitschrift für Geburtshilfe und Gynakologie 170(2): 151-162

Shmelev, N.A.; Krasheninnikova, M.A.; Klochkova, G.S.; Vil'shanskaia, F.L.; Kozulitsyna, T.I. 1974: Pyridoxine insufficiency in patients with tuberculosis during antibiotic therapy. Klinicheskaia Meditsina 52(12): 21-27

Kurbanova, E.G.; Mishchenko, B.P. 1985: Pyridoxine levels in the bodies of patients with dysmetabolic nephropathy. Pediatriia 10: 37-39

Udalov, I.F.; Khalatov, O.P. 1971: Pyridoxine metabolism and requirements in flight personnel. Voprosy Pitaniia 30(3): 12-18

Kriukova, N.A. 1966: Pyridoxine metabolism in neurotic patients during regular administration of thiamine. Voprosy Pitaniia 25(5): 51-55

Baĭramaliev, G.; Krasheninnikova, M.A.; Kolosovskaia, V.P.; Chukanov, V.I. 1982: Pyridoxine metabolism in pulmonary tuberculosis patients under rifampicin therapy in combination with isoniazid. Problemy Tuberkuleza 1: 58-62

Dordain, G.; Deffond, D. 1994: Pyridoxine neuropathies. Review of the literature. Therapie 49(4): 333-337

Schaeppi, U.; Krinke, G. 1982: Pyridoxine neuropathy: correlation of functional tests and neuropathology in beagle dogs treated with large doses of vitamin B6. Agents and Actions 12(4): 575-582

Anonymous 1973: Pyridoxine nutriture and monosodium glutamate utilization by rats. Nutrition Reviews 31(2): 70-71

Mirouze, J.; Orsetti, A.; Cartry, E. 1973: Pyridoxine para-chloro-phenoxy-isobutyrate. Analysis of hypolipidemic effects. La Nouvelle Presse Medicale 2(46): 3115-3116

Husain, S.A.; Saksena, H.C.; Kothari, R.P.; Marothi, P.S. 1971: Pyridoxine responsive anaemia (a case report with follow up of the case for one and one half years). Journal of the Association of Physicians of India 19(12): 875-878

Ueda, Y. 1972: Pyridoxine responsive anemia. Nihon Shonika Gakkai Zasshi. Acta Paediatrica Japonica 76(2): 65-67

Stephenson, J.B.; Byrne, K.E. 1983: Pyridoxine responsive epilepsy: expanded pyridoxine dependency?. Archives of Disease in Childhood 58(12): 1034

Hazra, D.K.; Wahal, P.K.; Maheshwari, B.B.; Bansal, O.P.; Kishore, B.; Pant, P.C.; Gupta, R.N. 1974: Pyridoxine responsive sideroblastic anemia. Indian Journal of Medical Sciences 28(4-5): 208-211

Duvoisin, R.C.; Yahr, M.D.; Coté, L.D. 1969: Pyridoxine reversal of L-dopa effects in Parkinsonism. Transactions of the American Neurological Association 94: 81-84

Boyde, T.R. 1995: Pyridoxine supplements in the carpal tunnel syndrome. Bmj 311(7005): 631

Artaeva, L.P. 1970: Pyridoxine supply in patients with atherosclerosis and hypertension. Voprosy Pitaniia 29(1): 16-20

Balcke, P.; Schmidt, P.; Zazgornik, J.; Kopsa, H.; Minar, E. 1983: Pyridoxine therapy in patients with renal calcium oxalate calculi. Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association 20: 417-421

Hajailay, R.; Sharan, R.; Agarwal, V.K.; Srivastava, A.K. 1983: Pyridoxine therapy in tetanus neonatorum. Indian Pediatrics 20(12): 935-939

Ordman, B. 1965: Cerebro-vascular episodes and the retina--variations on a theme. South African Medical Journal 39(41): 1040-1044

Vasile, A.; Goldberg, R.; Kornberg, B. 1984: Pyridoxine toxicity: report of a case. Journal of the American Osteopathic Association 83(11): 790-791

Boers, G.H.; Smals, A.G.; Drayer, J.I.; Trijbels, F.J.; Leermakers, A.I.; Kloppenborg, P.W. 1983: Pyridoxine treatment does not prevent homocystinemia after methionine loading in adult homocystinuria patients. Metabolism, Clinical and Experimental 32(4): 390-397

Alinei, P.; Guignard, J.P.; Jaeger, P. 1984: Pyridoxine treatment of type 1 hyperoxaluria. New England Journal of Medicine 311(12): 798-799

Yahr, M.D.; Duvoisin, R.C.; Côté, L.; Cohen, G. 1972: Pyridoxine, DOPA, and Parkinsonism. Advances in Biochemical Psychopharmacology 4: 185-194

Sguazzini-Viscontini, C. 1966: Pyridoxine, bone and calcium metabolism. Acta Vitaminologica 20(4): 143-149

Wainwright, T. 1969: Pyridoxine, pantothenate and methionine effects of H2S formation by Saccharomyces cerevisiae. Antonie van Leeuwenhoek 35: Suppl:g3-4

Das, U.N. 1981: Pyridoxine, thrombosis, and prostaglandins. Lancet 2(8247): 638

Schmidt, E. 1965: Pyridoxine--dependency. Paediatrica Indonesiana 5(1-2): 565-568

Raskin, N.H.; Fishman, R.A. 1965: Pyridoxine-deficiency neuropathy due to hydralazine. New England Journal of Medicine 273(22): 1182-1185

Gaull, G.E.; Rassin, D.K.; Sturman, J.A. 1968: Pyridoxine-dependency in homocystinuria. Lancet 2(7581): 1302

Krishnamoorthy, K.S. 1983: Pyridoxine-dependency seizure: report of a rare presentation. Annals of Neurology 13(1): 103-104

Aurich, H.; Neumann, W.; Fuchs, U. 1968: Pyridoxine-dependent changes in the chemical composition of the hyphae of Neurospora sitophila. Archiv für Mikrobiologie 61(1): 30-39

Lauras, B.; Drevon, B.; Rolland, M.O.; Teyssier, G.; Bovier-Lapierre, M.; Freycon, F. 1984: Pyridoxine-dependent convulsions : familial case. Pediatrie 39(3): 183-187

Adam, E.; Goor, M.; Delattre, B.; Farriaux, J.P.; Fontaine, G. 1972: Pyridoxine-dependent convulsions. Apropos of a further case. Pediatrie 27(1): 19-25

Van Waarde, W.M.; Tummers, R.F.; Bosschaart, A.N.; Hageman, G. 1995: Pyridoxine-dependent epilepsy in an infant. Nederlands Tijdschrift Voor Geneeskunde 139(33): 1694-1697

Crowell, G.F.; Roach, E.S. 1983: Pyridoxine-dependent seizures. American Family Physician 27(3): 183-187

Rosenberg, S.J.; Bennett, J.M. 1969: Pyridoxine-responsive anemia. New York State Journal of Medicine 69(11): 1430-1433

Hoagland, H.C.; Linman, J.W. 1972: Pyridoxine-responsive anemia. a preleukemic manifestation?. Minnesota Medicine 55(10): 891-895

Ueda, Y.; Murakami, M. 1972: Pyridoxine-responsive anemia. Report of a case in a child. Japanese Journal of Clinical Hematology 13(4): 477-484

Horrigan, D.L.; Harris, J.W. 1968: Pyridoxine-responsive anemias in man. Vitamins and Hormones 26: 549-571

Mudd, S.H. 1971: Pyridoxine-responsive genetic disease. Federation Proceedings 30(3): 970-976

Burkhart, C.G. 1982: Pyridoxine-responsive herpes gestationis. Archives of Dermatology 118(8): 535

Anonymous 1981: Pyridoxine-responsive homocystinuria. Nutrition Reviews 39(1): 16-18

Altay, C.; Gümrük, F. 1995: Pyridoxine-responsive sideroblastic anemia in four children. Pediatric Hematology and Oncology 12(2): 205-208

Kluka, V.; Hyánek, J.; Pavkovceková, O.; Tischler, V.; Pospisil, R.; Dóci, J. 1983: Pyridoxine-sensitive homocystinuria in 2 siblings. Ceskoslovenska Pediatrie 38(10): 585-589

Testa, S.; Calcagno, G.; Nurra, P.; Massetti, L. 1981: Pyridoxine-sensitive sideroblastic anemias. Survey of the literature and study of a case. Minerva Medica 72(49): 3345-3350

Shih, V.E.; Efron, M.L. 1970: Pyridoxine-unresponsive homocystinuria. New England Journal of Medicine 283(22): 1206-1208

Croizat, P.; Viala, J.J.; Karlin, R.; Bryon, P.A.; Revol, L. 1969: Pyridoxinemia after a loading dose, test of vitamin B 6 deficiency; its importance in hematology in the light of 149 measurements. Nouvelle Revue Francaise d'Hematologie 9(2): 177-190

Spisni, D.; Mariani, A.P. 1970: Pyridoxinuria and xanthurenuria in rabbits treated with parenteral administration of large doses of nicotinamide. Bollettino della Societa Italiana di Biologia Sperimentale 46(4): 206-207

Schroer, R.A.; Frieden, E.H. 1973: Pyridoxol biosynthesis by Saccharomyces fragilis. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 142(2): 369-373

Sklyarov LYu; Sbitneva, I.N.; Kopina, N.A.; Kugaevskaja, E.V. 1994: Pyridoxyl derivatives of peptides. a new class of angiotensin-converting enzyme inhibitors. American Biotechnology Laboratory 12(9): 12-13

Churchich, J.E.; Irwin, R. 1970: Pyridoxyl-5-phosphate-lysozyme. Physical studies. Biochimica et Biophysica Acta 214(1): 157-167

Jacob, E.; Doussinet, H. 1968: Pyridoxylate in neuropsychiatry. Therapeutic trial. Annales Medico-Psychologiques 2(4): 553-560

Pecon, J.M.; Blackburn, M.N. 1984: Pyridoxylation of essential lysines in the heparin-binding site of antithrombin IIi. Journal of Biological Chemistry 259(2): 935-938

Berezowski, L.; Dymek, W. 1970: Pyridyl derivatives of quinazoline-4 with expected pharmacological effect. Acta Poloniae Pharmaceutica 27(1): 11-16

Sergejew, T.; Hartmann, R.W. 1994: Pyridyl substituted benzocycloalkenes: new inhibitors of 17 alpha-hydroxylase/17,20-lyase (P450 17 alpha). Journal of Enzyme Inhibition 8(2): 113-122

Komissarov, I.V. 1970: Pyridyl- and pyridylalkyl-indolines as serotonin antagonists. Farmakologiia i Toksikologiia 33(4): 392-395

Hartmann, R.W.; Bayer, H.; Grün, G.; Sergejew, T.; Bartz, U.; Mitrenga, M. 1995: Pyridyl-substituted tetrahydrocyclopropa[a]naphthalenes: highly active and selective inhibitors of P450 arom. Journal of Medicinal Chemistry 38(12): 2103-2111

Ritter, J.A. 1969: Pyriform sinusostomy. JAMA 207(2): 367-368

Shumrick, D.A. 1967: Pyriformsinusosotomy. a useful technique for temporary or permanent tube feeding. Archives of Surgery 94(2): 277-279

Krechetova, E.P.; Grigor'ev, P.S. 1965: Pyrilen and hexonium treatment of patients with ulcer. Vrachebnoe Delo 10: 149-150

Rumiantsev, V.B.; Rymko, L.P.; Kidanova, Z.S. 1972: Pyrilene in preoperative treatment of patients with pulmonary and pleural tuberculosis. Sovetskaia Meditsina 35(7): 121-125

Herbert, V.; Waxman, S. 1969: Pyrimethamine effect on folate metabolism. New England Journal of Medicine 281(10): 565

Ragab, A.H. 1973: Pyrimethamine in central-nervous-system leukaemia. Lancet 1(7811): 1061

Akinyanju, O.; Goddell, J.C.; Ahmed, I. 1973: Pyrimethamine poisoning. British Medical Journal 4(5885): 147-148

Laing, A.B. 1970: Pyrimethamine resistance in Gambia: extension to the gametocytes of Plasmodium falciparum. Transactions of the Royal Society of Tropical Medicine and Hygiene 64(5): 791

Nguyen-Dinh, P.; Payne, D. 1980: Pyrimethamine sensitivity in Plasmodium falciparum: determination in vitro by a modified 48-hour test. Bulletin of the World Health Organization 58(6): 909-912

Jerusalem, C. 1966: Pyrimethamine therapy combined with paraaminobenzoic acid-free diet in experimental malaria infection(Plasmodium berghei). Klinische Wochenschrift 44(19): 1156-1158

Matthews, J.I.; Molitor, J.T.; Hunt, K.K. 1973: Pyrimethamine-induced leukopenia and thrombocytopenia in a patient with malaria and tropical sprue: case report. Military Medicine 138(5): 280-283

Jones, S.A. 1968: Pyrimethamine-resistant strains of human malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 62(4): 572

Puizillout, J.J.; Ternaux, J.P. 1971: Pyrimidal and bulbar activities triggered by vago-aortic soporific stimulation. Journal de Physiologie 63(6): 143a

Ohta, M.; Tashiro, N. 1968: Pyrimidal tract response to cortical stimulation in the rat. Japanese Journal of Physiology 18(4): 432-445

Ishida, Y.; Fujii, H.; Miwa, S. 1980: Pyrimidine 5'-nucleotidase deficiency: studies of five cases in two Japanese families. Hemoglobin 4(5-6): 683-691

Kelley, J.L.; Kelsey, J.E.; Hall, W.R.; Krochmal, M.P.; Schaeffer, H.J. 1981: Pyrimidine acyclic nucleosides, 1-[(2-Hydroxyethoxy)methyl]pyrimidines as candidate antivirals. Journal of Medicinal Chemistry 24(6): 753-756

Kelley, J.L.; Krochmal, M.P.; Schaeffer, H.J. 1981: Pyrimidine acyclic nucleosides. 5-Substituted 1-[(2-aminoethoxy)methyl]uracils as candidate antivirals. Journal of Medicinal Chemistry 24(4): 472-474

Niedzwicki, J.G.; el Kouni, M.H.; Chu, S.H.; Cha, S. 1981: Pyrimidine acyclonucleosides, inhibitors of uridine phosphorylase. Biochemical Pharmacology 30(15): 2097-2101

Gan, T.E.; Finch, P.D.; Brumley, J.L.; Hallam, L.J.; van der Weyden, M.B. 1984: Pyrimidine and purine activities in non-Hodgkin's lymphoma. Correlation with histological status and survival. European Journal of Cancer and Clinical Oncology 20(3): 361-368

Webster, D.R.; Simmonds, H.A.; Barry, D.M.; Becroft, D.M. 1981: Pyrimidine and purine metabolites in ornithine carbamoyl transferase deficiency. Journal of Inherited Metabolic Disease 4(1): 27-31

McCall, J.M.; Aiken, J.W.; Chidester, C.G.; DuCharme, D.W.; Wendling, M.G. 1983: Pyrimidine and triazine 3-oxide sulfates: a new family of vasodilators. Journal of Medicinal Chemistry 26(12): 1791-1793

Kulikowski, T.; Zawadzki, Z.; Shugar, D.; De Clercq, E. 1981: Pyrimidine arabinofuranosyl nucleosides with 5-substituted long, branched and unsaturated chains: synthesis and antiherpes properties. Nucleic Acids Symposium Series 9: 103-106

Danilov, V.I.; Sharafutdinov, M.R.; Malenkov, G.G.; Poltev, V.I. 1983: Pyrimidine base hydration in small clusters of water studied by the Monte Carlo method. Doklady Akademii Nauk SSSR 268(2): 485-488

Jyssum, S. 1983: Pyrimidine biosynthesis in Neisseria meningitidis. 1. Demonstration of enzyme activities. Acta Pathologica Microbiologica et Immunologica Scandinavica. Section B Microbiology 91(4): 251-255

Jyssum, S. 1983: Pyrimidine biosynthesis in Neisseria meningitidis. 2. Regulation of enzyme synthesis. Acta Pathologica Microbiologica et Immunologica Scandinavica. Section B Microbiology 91(4): 257-260

Bourget, P.A.; Natale, P.J.; Tremblay, G.C. 1971: Pyrimidine biosynthesis in rat liver: studies on the source of carbamoylphosphate. Biochemical and Biophysical Research Communications 45(4): 1109-1114

Blass, D.H.; Hunt, D.M. 1980: Pyrimidine biosynthesis in the dumpy mutants of Drosophila melanogaster. Molecular and General Genetics: Mgg 178(2): 437-442

Guseĭnov, V.A.; Mazin, A.L.; Vaniushin, B.F.; Belozerskiĭ, A.N. 1972: Pyrimidine blocks in DNA of fungi. Biokhimiia 37(2): 381-388

Khan, S.A.; Krandikar, S.S.; Jacob, T.M. 1972: Pyrimidine clusters in the deoxyribonucleic acid of Azotobacter vinelandii. Biochemical Journal 128(1): 67P-68P

Rözlcrová, A.; Drobníková, V. 1974: Pyrimidine decomposition in cultivated and non-cultivated soils. Zentralblatt für Bakteriologie Parasitenkunde Infektionskrankheiten und Hygiene. Zweite Naturwissenschaftliche Abt.: Allgemeine Landwirtschaftliche und Technische Mikrobiologie 129(3-4): 294-300

Senda, S.; Hirota, K.; Banno, K. 1972: Pyrimidine derivatives and related compounds. 15. Synthesis and analgetic and antiinflammatory activities of 1,3-substituted 5-amino-6-methyluracil derivatives. Journal of Medicinal Chemistry 15(5): 471-476

Senda, S.; Hirota, K.; Maeno, K. 1973: Pyrimidine derivatives and related compounds. 18. Studies in the synthesis and pharmacological activities of 2,4-dioxo-1,2,3,4,6,7-hexahydro-5H-cyclopenta (d) pyrimidine derivatives. Chemical and Pharmaceutical Bulletin 21(9): 1894-1900

Senda, S.; Hirota, K. 1971: Pyrimidine derivatives and related compounds. XI. Synthesis of bucolome related compounds. (6). Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 91(12): 1367-1371

Senda, S.; Hirota, K.; Yang, G.N.; Shirahashi, M. 1971: Pyrimidine derivatives and related compounds. XII. the Vilsmeier reaction of barbituric acid derivatives and uracil derivatives. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 91(12): 1372-1376

Senda, S.; Hirota, K.; Notani, J. 1974: Pyrimidine derivatives and related compounds. XX. Synthesis and analgetic and antiinflammatory activities of 1,3-disubstituted 5-dialkylaminomethyluracil derivatives. Chemical and Pharmaceutical Bulletin 22(5): 1179-1185

Senda, S.; Hirota, K.; Otani, O. 1974: Pyrimidine derivatives and related compounds. XXI. Synthesis and analgetic and antiinflammatory activities of 5-dimethylamino-6-methyl-4-oxodihydropyrimidine derivatives. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 94(5): 571-576

Senda, S.; Hirota, K. 1974: Pyrimidine derivatives and related compounds. XXII. Synthesis and pharmacological properties of 7-deazaxanthine derivatives. Chemical and Pharmaceutical Bulletin 22(7): 1459-1467

Senda, S.; Hirota, K. 1974: Pyrimidine derivatives and related compounds. XXIII. Synthesis and pharmacological properties of 9-deazaxanthine derivatives. Chemical and Pharmaceutical Bulletin 22(11): 2593-2598

Kim, D.H.; Santilli, A.A. 1968: Pyrimidine derivatives with antiamoebic activity. Journal of Medicinal Chemistry 11(6): 1227-1228

Nitta, Y.; Miyamoto, T.; Nebashi, T.; Yoneda, F. 1965: Pyrimidine derivatives. 3. the preparation and bacteriostatic activity of benzamidopyrimidines. Chemical and Pharmaceutical Bulletin 13(8): 901-906

Sekiya, T.; Hiranuma, H.; Hata, S.; Mizogami, S.; Hanazuka, M.; Yamada, S. 1983: Pyrimidine derivatives. 4. Synthesis and antihypertensive activity of 4-amino-2-(4-cinnamoylpiperazino)-6,7-dimethoxyquinazoline derivatives. Journal of Medicinal Chemistry 26(3): 411-416

Israel, M.; Schlein, H.N.; Maddock, C.L.; Farber, S.; Modest, E.J. 1966: Pyrimidine derivatives. 8. 5-Arylazopyrimidines and their inhibitory effects against transplantable mouse tumors. Journal of Pharmaceutical Sciences 55(6): 568-572

Okui, K.; Mizoguchi, M. 1972: Pyrimidine derivatives. VI. Studies on the syntheses of orotic acid, uracil and pyrimido(5,4-d)pyrimidine derivatives. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 92(7): 785-795

Sekiya, T.; Hiranuma, H.; Kanayama, T.; Hata, S.; Yamada, S. 1983: Pyrimidine derivatives. VI. Synthesis of 2-(1-piperazinyl)-5,6-polymethylenepyrimidine derivatives and determination of their hypoglycemic activity. Chemical and Pharmaceutical Bulletin 31(7): 2254-2261

Sekiya, T.; Hata, S.; Yamada, S. 1983: Pyrimidine derivatives. VII. Structure-activity relationship of hypoglycemic 4-amino-2-(1-piperazinyl)pyrimidines investigated by the adaptive least-squares method. Chemical and Pharmaceutical Bulletin 31(7): 2432-2437

Cooke, A.; Harris, W.J. 1981: Pyrimidine dimer excision in ageing human cells in tissue culture. International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine 39(2): 223-226

Rahn, R.O.; Landry, L.C. 1971: Pyrimidine dimer formation in poly (d-dT) and apurinic acid. Biochimica et Biophysica Acta 247(2): 197-206

Merriam, V.; Gordon, M.P. 1967: Pyrimidine dimer formation in ultraviolet irradiated TMV-RNA. Photochemistry and Photobiology 6(5): 309-319

Morgan, T.L.; Redpath, J.L.; Ward, J.F. 1984: Pyrimidine dimer induction in E. coli DNA by Cerenkov emission associated with high energy X-irradiation. International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine 46(4): 443-449

Bonura, T.; Radany, E.H.; McMillan, S.; Love, J.D.; Schultz, R.A.; Edenberg, H.J.; Friedberg, E.C. 1982: Pyrimidine dimer-DNA glycosylases: studies on bacteriophage T4-infected and on uninfected Escherichia coli. Biochimie 64(8-9): 643-654

Mennigmann, H.D. 1972: Pyrimidine dimers as pre-mutational lesions in Escherichia coli WP2 Hcr. Molecular and General Genetics: Mgg 117(2): 167-186

Setlow, R.B.; Carrier, W.L.; Bollum, F.J. 1965: Pyrimidine dimers in UV-irradiated poly dI:dC. Proceedings of the National Academy of Sciences of the United States of America 53(5): 1111-1118

Ellison, M.J.; Childs, J.D. 1981: Pyrimidine dimers induced in Escherichia coli DNA by ultraviolet radiation present in sunlight. Photochemistry and Photobiology 34(4): 465-469

Small, G.D.; Tao, M.; Gordon, M.P. 1968: Pyrimidine hydrates and dimers in ultraviolet-irradiated tobacco mosaic virus ribonucleic acid. Journal of Molecular Biology 38(1): 75-87

Van Der Weyden, M.B.; Hayman, R.J.; Rose, I.S. 1984: Pyrimidine metabolism in folate deficient lymphoblasts. Advances in Experimental Medicine and Biology 165 Pt A: 525-529

Sugiura, Y.; Fujioka, S.; Yoshida, S. 1984: Pyrimidine metabolism in human hematodyscrasial cells: studies of intermediates in pyrimidine de novo pathway. Japanese Journal of Clinical Hematology 25(10): 1581-1586

Breitman, T.R.; Perry, S.; Cooper, R.A. 1966: Pyrimidine metabolism in human leukocytes. 3. the utilization of thymine for DNA-thymine synthesis by leukemic leukocytes. Cancer Research 26(11): 2282-2285

Cooper, R.A.; Perry, S.; Breitman, T.R. 1966: Pyrimidine metabolism in human leukocytes. I. Contribution of exogenous thymidine to DNA-thymine and its effect on thymine nucleotide synthesis in leukemic leukocytes. Cancer Research 26(11): 2267-2275

Smith, L.H. 1973: Pyrimidine metabolism in man. New England Journal of Medicine 288(15): 764-771

Peters, G.J.; Oosterhof, A.; Veerkamp, J.H. 1983: Pyrimidine metabolism in peripheral and phytohemagglutinin-stimulated mammalian lymphocytes. International Journal of Biochemistry 15(1): 51-55

Peters, G.J.; Veerkamp, J.H. 1984: Pyrimidine metabolism in rat brain cortex and liver. Advances in Experimental Medicine and Biology 165 Pt A: 531-534

Rosson, R.A.; Rittenberg, S.C. 1981: Pyrimidine metabolism of Bdellovibrio bacteriovorus grown intraperiplasmically and axenically. Journal of Bacteriology 146(1): 108-116

Vandermeers-Piret, M.C.; Camus, J.; Christophe, J. 1966: Pyrimidine metabolism of the liver of rats deficient in lysine and threonine or recovering from this deficiency. Bulletin de la Societe de Chimie Biologique 48(4): 547-567

Shibui, S. 1984: Pyrimidine nucleoside phosphorylase in brain tumors and anti-tumor effect of 5'-DFUR. Neurologia Medico-Chirurgica 24(2): 65-72

Fox, J.J. 1969: Pyrimidine nucleoside transformations via anhydronucleosides. Pure and Applied Chemistry. Chimie Pure et Appliquee 18(1): 223-255

Wolfrom, M.L.; Bhat, H.B.; Conigliaro, P.J. 1971: Pyrimidine nucleosides of 2-amino-2-deoxy-D-galactose. Carbohydrate Research 20(2): 375-381

Wolfrom, M.L.; Conigliaro, P.J.; Bhat, H.B. 1971: Pyrimidine nucleosides of the furanose form of 2-amino-2-deoxy-D-glucose. Carbohydrate Research 20(2): 383-390

Wolfrom, M.L.; Conigliaro, P.J. 1971: Pyrimidine nucleosides of the furanose form of 2-amino-2-deoxy-D-xylose. Carbohydrate Research 20(2): 391-398

Kanai, T.; Ichino, M.; Hoshi, A.; Kanzawa, F.; Kuretani, K. 1972: Pyrimidine nucleosides. 5. Syntheses of carcinostatic halogenocyclonucleosides. Journal of Medicinal Chemistry 15(12): 1218-1221

Kanai, T.; Ichino, M. 1974: Pyrimidine nucleosides. 6. Syntheses and anticancer activities of N4-substituted 2,2'-anhydronucleosides. Journal of Medicinal Chemistry 17(10): 1076-1078

Winkley, M.W.; Robins, R.K. 1968: Pyrimidine nucleosides. I. the synthesis of 6-methylcytidine, 6-methyluridine, and related 6-methylpyrimidine nucleosides. Journal of Organic Chemistry 33(7): 2822-2827

Winkley, M.W.; Robins, R.K. 1969: Pyrimidine nucleosides. II. the direct glycosidation of 2,6-disubstituted 4-pyrimidones. Journal of the Chemical Society. Perkin Transactions 1 5: 791-796

Kanai, T.; Ichino, M.; Kojima, T. 1969: Pyrimidine nucleosides. II. the synthesis of unnatural pyrimidine nucleosides saturated at 5,6-double bond. Chemical and Pharmaceutical Bulletin 17(4): 650-652

Winkley, M.W. 1970: Pyrimidine nucleosides. IV. Reactions of 3-(beta-D-ribofuranosyl)-uracils. Journal of the Chemical Society. Perkin Transactions 1 10: 1365-1370

Winkley, M.W. 1970: Pyrimidine nucleosides. V. Reactions of 3-(beta-D-ribofuranosyl)-uracils and related compounds. Journal of the Chemical Society. Perkin Transactions 1 13: 1869-1874

Paglia, D.E.; Valentine, W.N.; Keitt, A.S.; Brockway, R.A.; Nakatani, M. 1983: Pyrimidine nucleotidase deficiency with active dephosphorylation of dTMP: evidence for existence of thymidine nucleotidase in human erythrocytes. Blood 62(5): 1147-1149

Kritskiĭ, G.A.; Abidov, A.A.; Surina, T.I. 1969: Pyrimidine nucleotide blocks of DNA in the effect of ionizing radiation on the animal organism. Radiobiologiia 9(5): 675-681

Neuhard, J. 1968: Pyrimidine nucleotide metabolism and pathways of thymidine triphosphate biosynthesis in Salmonella typhimurium. Journal of Bacteriology 96(5): 1519-1527

Rossi, A.; Aussedat, J.; Olivarès, J.; Ray, A.; Verdys, M. 1984: Pyrimidine nucleotide metabolism in cardiac hypertrophy. European Heart Journal 5 Suppl F: 155-162

Uziel, M.; Selkirk, J.K. 1980: Pyrimidine nucleotide pool changes during the cell cycle and quiescence. Pyrimidine excretion and metabolic isolation of the pyrimidine mononucleoside polyphosphate pool. Journal of Biological Chemistry 255(23): 11227-11232

Matsushita, S.; Fanburg, B.L. 1970: Pyrimidine nucleotide synthesis in the normal and hypertrophying rat heart. Relative importance of the de novo and "salvage" pathways. Circulation Research 27(3): 415-428

Wang, S.Y.; Rhoades, D.F. 1971: Pyrimidine phototetramer. Journal of the American Chemical Society 93(10): 2554-2556

Dennis, P.P.; Herman, R.K. 1970: Pyrimidine pools and macromolecular composition of pyrimidine-limited Escherichia coli. Journal of Bacteriology 102(1): 118-123

Brown, D.J.; Ford, P.W. 1969: Pyrimidine reactions. XIX. Aminolysis and hydrolysis of sulphoxides and sulphones derived from 2-(p-substituted phenylthio)-pyrimidines. Journal of the Chemical Society. Perkin Transactions 1 19: 2720-2723

Brown, D.J.; Lee, T.C. 1970: Pyrimidine reactions. XX. Thermal rearrangement of 5-(p-substituted phenyl)-2(and 4)-methoxypyrimidines. Journal of the Chemical Society. Perkin Transactions 1 2: 214-219

De Zeeuw, J.R.; Tynan, E.J. 1969: Pyrimidine reversal of emimycin inhibition of Escherichia coli. Journal of Antibiotics 22(8): 386-387

Krajewska, E.; Shugar, D. 1982: Pyrimidine ribonucleoside phosphorylase activity vs 5- and/or 6-substituted uracil and uridine analogues, including conformational aspects. Biochemical Pharmacology 31(6): 1097-1102

Ling, V. 1972: Pyrimidine sequences from the DNA of bacteriophages fd, fl, and phi X174. Proceedings of the National Academy of Sciences of the United States of America 69(3): 742-746

Darby, G.K.; Dumas, L.B.; Sinsheimer, R.L. 1970: Pyrimidine sequences in the complementary strand of the replicative form of bacteriophage phi-X174 DNA. Journal of General Microbiology 63(3): X

Petkov, P. 1981: Pyrimidine stimulation of regeneration and protective mechanisms in surgery. Khirurgiia 34(6): 562-564

Caroline, D.F. 1969: Pyrimidine synthesis in Neurospora crassa: gene-enzyme relationships. Journal of Bacteriology 100(3): 1371-1377

Appel, S.H.; Silberberg, D.H. 1968: Pyrimidine synthesis in tissue culture. Journal of Neurochemistry 15(12): 1437-1443

Van Kreijl, C.F.; Borst, P.; Flavell, R.A.; Hollenberg, C.P. 1972: Pyrimidine tract analysis of mtDNA from a "low-density" petite mutant of yeast. Biochimica et Biophysica Acta 277(1): 61-70

Ehrlich, S.D.; Thiery, J.P.; Bernardi, G. 1973: Pyrimidine tracts of the (A + T)-rich satellite DNA from Cancer pagurus. Biochimica et Biophysica Acta 312(4): 633-636

Gauri, K.K. 1970: Pyrimidine type enzyme inhibitors. I. Design of active pyrimidines of virostatic value. ChemoTherapy 15(4): 201-208

Cocucci, S.M.; Gianani, L. 1974: Pyrimidine utilization by exponentially growing and starved cells of Rhodotorula gracilis. Experientia 30(4): 337-338

Skoda, J. 1972: Pyrimidine- and purine-type antimetabolites. Casopis Lekaru Ceskych 111(45): 1060-1061

Kritskiĭ, G.A.; Surina, T.I. 1968: Pyrimidine-nucleotide fragments of the DNA fraction of bone marrow in normal and x-irradiated animals. Biokhimiia 33(4): 706-712

Radford, A. 1970: Pyrimidine-requiring suppressor mutations of arginine-3 in Neurospora and their bearing on the structure of the pyrimidine-3 locus. Molecular and General Genetics: Mgg 107(2): 97-106

Fast, R.; Sköld, O. 1973: Pyrimidine-ribonucleotide pools and their turnover in phage T4-infected Escherichia coli cells. European Journal of Biochemistry 38(1): 40-45

Garro, A.J.; Erlanger, B.F.; Beiser, S.M. 1971: Pyrimidine-specific antibodies: reaction with DNA's of differing base compositions. Journal of Immunology 106(2): 442-449

Williams, L.G.; Davis, R.H. 1970: Pyrimidine-specific carbamyl phosphate synthetase in Neurospora crassa. Journal of Bacteriology 103(2): 335-341

Rubin, C.M.; Schmid, C.W. 1980: Pyrimidine-specific chemical reactions useful for DNA sequencing. Nucleic Acids Research 8(20): 4613-4619

Alekhin, E.K. 1969: Pyrimidines and the function of the reticulo-endothelial system. Farmakologiia i Toksikologiia 32(1): 68-70

Bilich, G.L.; Tishchenko, A.L. 1967: Pyrimidines and the functional state of the liver in children with surgical diseases. Voprosy Okhrany Materinstva i Detstva 12(3): 89-90

Goloshchapov, N.M.; Dzhegutanov, B.S.; Zaika, G.F. 1968: Pyrimidines in the complex therapy of patients with leprosy. Vestnik Dermatologii i Venerologii 42(10): 75-78

Goloshchapov, N.M.; Zaika, G.F. 1970: Pyrimidines in the complex treatment of patients with leprosy. Sovetskaia Meditsina 33(8): 150-152

Ianovskaia, I.V. 1969: Pyrimidines in the therapy of infectious hepatitis in children and their effect on the blood serum and urine amino acid composition. Voprosy Okhrany Materinstva i Detstva 14(8): 23-26

O'Brien, D.E.; Cheng, C.C.; Peleiderer, W. 1966: Pyrimidines. 18. 2,4-diamino-5-nitro-6-arylaminopyrimidines. Nitration study of 2,4-diamino-6-chloropyrimidine and a literature correction. Journal of Medicinal Chemistry 9(4): 573-575

Gray, E.A.; Hulley, R.M.; Snell, B.K. 1970: Pyrimidines. 3. Synthesis of some 5-alkylthiopyrimidines. Journal of the Chemical Society. Perkin Transactions 1 7: 986-989

Brossmer, R.; Ziegler, D. 1970: Pyrimidines. 8. Synthesis and properties of uracil-4-carbaldehyde hydrazone. the first inner orbital complex of a pyrimidine with copper. Chemische Berichte 103(1): 17-22

Shadbolt, R.S.; Ulbricht, T.L. 1968: Pyrimidines. IV. the preparation of some analogues of vitamin B6. Journal of the Chemical Society. Perkin Transactions 1 10: 1203-1208

Blank, H.U.; Wempen, I.; Fox, J.J. 1970: Pyrimidines. IX. a new synthesis of 8-azapurines and v-triazolo[4,5-b]pyridines. Journal of Organic Chemistry 35(4): 1131-1138

Gershon, H.; Parmegiani, R.; D'Ascoli, R. 1967: Pyrimidines. V. Some higher 5-substituted 2,4,6-trichloropyrimidines. Journal of Medicinal Chemistry 10(1): 113-115

Watanabe, K.A.; Friedman, H.A.; Cushley, R.J.; Fox, J.J. 1966: Pyrimidines. VI. a novel degradation of 3-methyl-4-thiouracil. Journal of Organic Chemistry 31(9): 2942-2945

Otter, B.A.; Taube, A.; Fox, J.J. 1971: Pyrimidines. XI. the conversion of 5-hydroxyuracils into 6-allyluracils via Claisen rearrangements. Journal of Organic Chemistry 36(9): 1251-1255

O'Brien, D.E.; Noell, C.W.; Robins, R.K.; Cheng, C.C. 1966: Pyrimidines. XVI. 2,4,5-Triaminopyrimidines and related compounds. Journal of Medicinal Chemistry 9(1): 121-126

O'Brien, D.E.; Weinstock, L.T.; Cheng, C.C. 1968: Pyrimidines. XXII. 2,4-Diamino-6-aryl-amino-5-pyrimidinecarboxaldehydes and related compounds. Journal of Medicinal Chemistry 11(2): 387-388

Kim, D.H.; Santilli, A.A. 1969: Pyrimido [4,5-e] (1,4) diazepin-5-ones and 4,4-ethylenediaminobis (2-phenylpyrimidine-5-carboxylic acid) diethyl esters. Journal of Medicinal Chemistry 12(6): 1121-1122

Rosowsky, A.; Papathanasopoulos, N. 1974: Pyrimido(4,5-c)isoquinolines. 2. Synthesis and biological evaluation of some 6-alkyl-,6-aralkyl-, and 6-aryl-1,3-diamino-7,8,9,10-tetrahydropyrimido(4,5-c)isoquinolines as potential folate antagnoists 1. Journal of Medicinal Chemistry 17(12): 1272-1276

Temple, C.; Kussner, C.L.; Montgomery, J.A. 1971: Pyrimido(5,4-e)-as-triazines. VI. the preparation of some 5-substituted 7-aminopyrimido(5,4-e)-as-triazines. Journal of Organic Chemistry 36(23): 3502-3506

Temple, C.; Kussner, C.L.; Montgomery, J.A. 1974: Pyrimido(5,4-e)-as-triazines. VII. Synthesis of 7-aza analogs of pteroic and folic acids. Journal of Organic Chemistry 39(19): 2866-2871

Koyama, S.; Manning, J.W.; Takeuchi, T. 1982: Pyrimido-pyrimidine derivative, RA642, a central pressor agent in cat endotoxin shock. European Journal of Pharmacology 83(3-4): 191-198

Arion, A.F.; Ciolex, M.; Joseph, E.; Polliot, L. 1969: Pyrimidyl-piperonyl-piperazine in ophthalmology: 114 cases. Bulletin des Societes d'Ophtalmologie de France 69(5-6): 511-517

Wedig, J.H.; Barbee, S.J.; Mitoma, C. 1984: Pyrithione: plasma metabolite in man. Fundamental and Applied Toxicology: Official Journal of the Society of Toxicology 4(3 Part 1): 497-498

Reuter, H. 1974: Pyrithioxin. Zeitschrift für Allgemeinmedizin 50(34): 1577-1578

Tosković, B. 1983: Pyrithioxin in the treatment of patients with rheumatoid arthritis (comparative study with D-penicillamine). Reumatizam 30(3): 60-68

Nelemans, F.A. 1966: Pyrithioxine (Encephabol); report of a double blind study of the action of pyrithioxine (Encephabol) in patients suffering from central deafness. Nederlands Tijdschrift Voor Geneeskunde 110(45): 2002-2005

Zelvelder, W.G. 1965: Pyrithioxine (encephabol). Report of a double-blind study. Nederlands Tijdschrift Voor Geneeskunde 109(37): 1734-1736

Camus, J.P.; Crouzet, J.; Prier, A.; Bergevin, H. 1981: Pyrithioxine and thiopronine: new penicillamine-like drugs in rheumatoid arthritis. Journal of Rheumatology. Suppl 7: 175-177

Schreiber, K.G. 1965: Pyrithioxine in the treatment of craniocerebral injuries. Der Landarzt 41(26): 1126-1128

Offenloch, K.; Vossius, G. 1970: Pyritinol-induced changes in the circulation, respiration and spontaneous activity of neurons in the amygdaloid nucleus of cats. Naunyn-Schmiedebergs Archiv für Pharmakologie 266(4): 415-416

Weichsel, M.E.; Hoogenraad, N.J.; Levine, R.L.; Kretchmer, N. 1972: Pyrmidine biosynthesis during development of rat cerebellum. Pediatric Research 6(8): 682-686

Yarom, R.; Meiri, U. 1973: Pyroantimonate precipitates in frog skeletal muscle. Changes produced by alterations in composition of bathing fluid. Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society 21(2): 146-154

Donev, S.; Petkov, P. 1981: Pyroantimonate-bound cations in the beta-cells of spiny mice pancreas (Acomys cahirinus). Cellular and Molecular Biology Including Cyto-Enzymology 27(4): 341-345

Huang, M.T.; Grollman, A.P. 1973: Pyrocatechol violet: an inhibitor of initiation of protein synthesis. Biochemical and Biophysical Research Communications 53(4): 1049-1059

Palm, D. 1972: Pyrocatecholamines and myocardial function. Verhandlungen der Deutschen Gesellschaft für Kreislaufforschung 38: 44-54

Parshley, P.F.; Kiessling, P.J.; Antonius, J.A.; Connell, R.S.; Miller, S.H.; Green, F.H. 1982: Pyroclastic flow injury. Mount St. Helens, May 18, 1980. American Journal of Surgery 143(5): 565-568

Monnet, P.; Vaillaud, J.C.; Gauthier, J. 1967: Pyrocyanic bacillus infections in premature infants. (Cases observed at the Centre des Prématurés de Lyon). La Revue Lyonnaise de Medecine 16(2): 87-100

Eberle, F.; Adler, G.; Roth, S.L. 1980: Pyroderma fistulans sinifica associated with congenital alpha-1-antitrypsin deficiency. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 31(2): 100-104

Morin, J.Y.; Holleville, P. 1970: Pyrodoxilate in deficiency syndromes. Annales Medico-Psychologiques 1(2): 297-300

Athenstaedt, H. 1971: Pyroelectric and piezoelectric behaviour of human dental hard tissues. Archives of Oral Biology 16(5): 495-501

Athenstaedt, H. 1974: Pyroelectric and piezoelectric properties of vertebrates. Annals of the New York Academy of Sciences 238: 68-94

Athenstaedt, H. 1972: Pyroelectric behaviour of integument structures and of thermo-, photo- and mechanoreceptors. Zeitschrift für Anatomie und Entwicklungsgeschichte 136(3): 249-271

Collins, M.A.; Gordon, R.; Bigdeli, M.G.; Rubenstein, J.A. 1974: Pyrogallol potentiates acetaldehyde blood levels during ethanol oxidation in rats. Chemico-Biological Interactions 8(2): 127-130

Markham, C.; Reed, P.I. 1980: Pyrogastrone treatment of peptic oesophagitis: analysis of 104 patients treated during a 3 1/2-year period. Scandinavian Journal of Gastroenterology. Suppl 65: 73-82

Port, F.K.; Bernick, J.J. 1983: Pyrogen and endotoxin reactions during hemodialysis. Contributions to Nephrology 36: 100-106

Cox, C.G.; Rafter, G.W. 1971: Pyrogen and enzyme release from rabbit blood leukocytes promoted by endotoxin and polyinosinic polycytidylic acid. Biochemical Medicine 5(3): 227-236

Feldberg, W.; Gupta, K.P. 1973: Pyrogen fever and prostaglandin-like activity in cerebrospinal fluid. Journal of Physiology 228(1): 41-53

Walczyński, Z. 1969: Pyrogen in the stimulation treatment in children. Wiadomosci Lekarskie 22(5): 491-493

Pool, M.; McLeod, B.C. 1995: Pyrogen reactions to human serum albumin during plasma exchange. Journal of Clinical Apheresis 10(2): 81-84

Tutunjian, R.S. 1982: Pyrogen removal by ultrafiltration. Progress in Clinical and Biological Research 93: 319-327

Strobel, K. 1972: Pyrogen studies on inhalation-waters using intravenous injection and inhalation. Das Deutsche Gesundheitswesen 27(34): 1618-1623

Kanoh, S. 1982: Pyrogen test and Limulus test--on the relation between the 2 tests. Eisei Shikenjo Hokoku. Bulletin of National Institute of Hygienic Sciences 100: 20-33

Kertai, P. 1967: Pyrogen test in antipyretic drugs. Acta Pharmaceutica Hungarica 37(2): 85-90

Weary, M. 1984: Pyrogen testing of parenteral products--status report. Journal of Parenteral Science and Technology: a Publication of the Parenteral Drug Association 38(1): 20-23

Eibert, J. 1972: Pyrogen testing: horseshoe crabs vs. rabbits. Bulletin of the Parenteral Drug Association 26(6): 253-260

Khvoĭnitskiĭ, A.I. 1969: Pyrogen therapy in ophthalmology. Vestnik Oftalmologii 82(4): 80-84

Savel'eva, L.A.; Kotova, T.G.; Plaksina, G.V.; Dedikova, L.A.; Timokova, V.S. 1980: Pyrogen treatment of liver cirrhosis in children. Voprosy Okhrany Materinstva i Detstva 25(9): 26-29

Garnett, E.S.; Bayly, R.J.; Marlow, C.G. 1969: Pyrogen-free 113Inm scanning agents. British Journal of Radiology 42(501): 709-710

Eisenman, J.S. 1969: Pyrogen-induced changes in the thermosensitivity of septal and preoptic neurons. American Journal of Physiology 216(2): 330-334

Yoshida, M.; Kawasaki, H.; Kano, S. 1971: Pyrogen. 4. Some physiological properties of leukocytic pyrogen. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 67(2): 125-130

Frolov, V.M.; Shlykova, S.I. 1984: Pyrogenal in the combined therapy of erysipelatous inflammation. Sovetskaia Meditsina 1: 95-98

Turanova, E.N.; Skuratovich, A.A.; Afanas'ev, B.A. 1969: Pyrogenal in the therapy of inflammatory diseases of female urogenital organs. Vestnik Dermatologii i Venerologii 43(5): 76-79

Kukushkin, A.M. 1970: Pyrogenal in the therapy of nongonococcal urethritis and its complications. Vestnik Dermatologii i Venerologii 44(3): 80-83

Zuev, V.S.; Khil'ko, G.I. 1971: Pyrogenal in the treatment of persons who have suffered tuberculosis for a prolonged period. Problemy Tuberkuleza 49(10): 40-44

Kazan, M.Z.; Frigo, I.V.; Novikova, S.I.; Klevtsova, G.I. 1972: Pyrogenal in treatment of patients with active and latent forms of syphilis. Vestnik Dermatologii i Venerologii 46(1): 62-65

Tsirul'nikov, E.M. 1970: Pyrogenal therapy of patients with cochlear neuritis and with adhesive alterations in the middle ear. Zhurnal Ushnykh Nosovykh i Gorlovykh Boleznei 30(4): 50-54

Karagezian, M.A.; Zlochevskaia, T.N. 1968: Pyrogenal therapy of psoriasis patients. Vrachebnoe Delo 7: 136-137

Tsukanova, V.N. 1968: Pyrogenal treatment of patients with cochlear neuritis. Vestnik Otorinolaringologii 30(4): 27-32

Zubov, A.P. 1968: Pyrogenal treatment of patients with infectious nonspecific polyarthritis. Sovetskaia Meditsina 31(8): 55-58

Korik, L.M. 1973: Pyrogenal treatment of the resistant forms of urogenital trichomoniasis. Vestnik Dermatologii i Venerologii 47(6): 80-83

Shamshin, N.F.; Malykh, V.A. 1980: Pyrogenal-vaccine therapy of men with gonorrhea. Vestnik Dermatologii i Venerologii 11: 62-64

Hergott, J.; Klavehn, M. 1971: Pyrogene test with recording apparatus and improved animal boxes and a survey on pyrogenes. Arzneimittel-Forschung 21(4): 553-559

Nathal, E.; Sierra-Honigmann, M.R.; de la Cabada Cortés, F.J. 1984: Pyrogenic activity in the sera of febrile patients mediated by endogenous pyrogen and activators of adenyl cyclase. Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 36(2): 125-131

Castrová, A.; Pekárek, J.; Johanovský, J. 1972: Pyrogenic activity of antilymphocyte and of antipolymorphonuclear sera. Zeitschrift für Immunitatsforschung Experimentelle und Klinische Immunologie 144(3): 221-232

Rotta, J.; Schleifer, K.H. 1974: Pyrogenic activity of bacterial mucopeptides. Journal of Hygiene Epidemiology Microbiology and Immunology 18(1): 50-59

Lesnikov, V.A.; Efremov, O.M.; Simbirtsev, A.S.; Van Damme, J.; Billiau, A. 1994: Pyrogenic activity of human native and human recombinant interleukins-1 beta: stabilization with albumin enhances the pyrogenic action of recombinant IL-1 beta delivered into the rabbit brain. International Journal of Neuroscience 77(3-4): 267-275

Rotta, J.; Rýc, M. 1974: Pyrogenic and thrombocytolytic effect of bacterial mucopeptide. Ceskoslovenska Epidemiologie Mikrobiologie Imunologie 23(4-5): 236-245

Becker, R. 1968: Pyrogenic infections in the jaw region of the child. Deutsche Zahnarztliche Zeitschrift 23(12): 1295-1302

Kanoh, S.; Kohlhage, H.; Siegert, R. 1968: Pyrogenic principle of the ribonucleic acid from the yeast Candida utilis. Journal of Bacteriology 96(3): 738-743

Dinarello, C.A.; Ward, S.B.; Wolff, S.M. 1973: Pyrogenic properties of bleomycin (NSC-125066). Cancer ChemoTherapy Reports 57(4): 393-398

Reyes, M.P.; Ganguly, S.; Fowler, M.; Brown, W.J.; Gatmaitan, B.G.; Friedman, C.; Lerner, A.M. 1980: Pyrogenic reactions after inadvertent infusion of endotoxin during cardiac catheterizations. Annals of Internal Medicine 93(1): 32-35

Liu, J.C.; Shyy, T.T. 1980: Pyrogenic responses in the decerebrate monkey (Macaca cyclopis). Experimental Neurology 67(3): 481-491

Clark, W.G.; Page, J.S. 1968: Pyrogenic responses to staphylococcal enterotoxins a and B in cats. Journal of Bacteriology 96(6): 1940-1946

Brunson, K.W.; Watson, D.W. 1974: Pyrogenic specificity of streptococcal exotoxins, staphylococcal enterotoxin, and gram-negative endotoxin. Infection and Immunity 10(2): 347-351

Mochida, K.; Ogawa, Y.; Kano, S. 1974: Pyrogenic susbstances. (11). Relationship between the molecular size of bacterial pyrogen and its central action. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 70(3): 359-363

Lena, P. 1980: Pyrogenicity and microbiota of injectable solutions. Bollettino Chimico Farmaceutico 119(1): 1-22

Dabbah, R.; Ferry, E.; Gunther, D.A.; Hahn, R.; Mazur, P.; Neely, M.; Nicholas, P.; Pierce, J.S.; Slade, J.; Watson, S.; Weary, M.; Sanford, R.L. 1980: Pyrogenicity of E. coli 055:b5 endotoxin by the USP rabbit test--a HIMA collaborative study. Journal of the Parenteral Drug Association 34(3): 212-216

Lindsay, H.L.; Trown, P.W.; Brandt, J.; Forbes, M. 1969: Pyrogenicity of poly I. poly C in rabbits. Nature 223(5207): 717-718

Shanbrom, E. 1982: Pyrogenicity versus endotoxicity: which is more significant?. Progress in Clinical and Biological Research 93: 105-113

Miró Forteza, A. 1971: Pyrogens. Revista Espanola de Anestesiologia y Reanimacion 18(4): 615-635

Scheer, R. 1984: Pyrogens and the Limulus test. Pharmazie in Unserer Zeit 13(5): 137-146

Zubov, A.P. 1969: Pyrogens in the treatment of patients with nonspecific infectious (rheumatoid) polyarthritis. Vrachebnoe Delo 7: 59-62

Ibayashi, J. 1968: Pyroglobulin. Rinsho Byori. Japanese Journal of Clinical Pathology 16(7): 571-577

Ibayashi, J.; Fukuda, M.; Matsuda, M.; Urushizaki, I. 1966: Pyroglobulin--with reference to a personal case. Nihon Rinsho. Japanese Journal of Clinical Medicine 24(9): 1671-1679

Watanabe, T.; Oshima, T.; Minamizawa, S.; Kozima, A.; Kimura, T.; Suzuki, Z.; Itoh, C.; Yoshioka, N. 1980: Pyroglobulinemia developing in a case of IgA-lambda type multiple myeloma presenting as plasmocytoma of the mandible. Japanese Journal of Clinical Hematology 21(7): 984-990

Aoki, T.; Kawai, T. 1973: Pyroglobulinemia, a review. Japanese Journal of Clinical Hematology 14(2): 113-128

Invernizzi, F.; Cattaneo, R.; Rosso di San Secondo, V.; Balestrieri, G.; Zanussi, C. 1973: Pyroglobulinemia. A report of eight patients with associated paraproteinemia. Acta Haematologica 50(2): 65-74

Strömme, J.H.; Solberg, H.E. 1973: Pyroglutamate hydrolase: kinetic properties of enzyme from rat liver. Scandinavian Journal of Clinical and Laboratory Investigation 32(3): 233-237

Caccia, S.; Ghezzi, P.; Garattini, S.; Salmona, M.; Takasaki, Y.; Torii, K. 1983: Pyroglutamate kinetics and neurotoxicity studies in mice. Toxicology Letters 16(3-4): 225-229

Antonelli, T.; Carlà, V.; Lambertini, L.; Moroni, F.; Bianchi, C. 1984: Pyroglutamic acid administration modifies the electrocorticogram and increases the release of acetylcholine and GABA from the guinea-pig cerebral cortex. Pharmacological Research Communications 16(2): 189-197

Abraham, G.N.; Podell, D.N. 1981: Pyroglutamic acid. Non-metabolic formation, function in proteins and peptides, and characteristics of the enzymes effecting its removal. Molecular and Cellular Biochemistry 38 Spec No (Part 1): 181-190

Roesel, R.A.; Hommes, F.A.; Samper, L. 1981: Pyroglutamic aciduria (5-oxoprolinuria) without glutathione synthetase deficiency and with decreased pyroglutamate hydrolase activity. Journal of Inherited Metabolic Disease 4(2): 89-90

Larsson, A.; Zetterström, R.; Hagenfeldt, L.; Andersson, R.; Dreborg, S.; Hörnell, H. 1974: Pyroglutamic aciduria (5-oxoprolinuria), an inborn error in glutathione metabolism. Pediatric Research 8(10): 852-856

Morishita, H.; Nagaya, S.; Nakajima, T.; Kawase, A.; Ohya, A.; Sugiyama, S.; Kamiya, K.; Watanabe, I.; Togari, H.; Suzuki, Y. 1984: Pyroglutamic aciduria in propionyl CoA carboxylase deficiency. Journal of Inherited Metabolic Disease 7(3): 139-140

Jellum, E.; Kluge, T.; Börresen, H.C.; Stokke, O.; Eldjarn, L. 1970: Pyroglutamic aciduria--a new inborn error of metabolism. Scandinavian Journal of Clinical and Laboratory Investigation 26(4): 327-335

Hagenfeldt, L.; Larsson, A.; Zetterström, R. 1974: Pyroglutamic aciduria. Studies in an infant with chronic metabolic acidosis. Acta Paediatrica Scandinavica 63(1): 1-8

Eldjarn, L.; Jellum, E.; Stokke, O. 1973: Pyroglutamic aciduria: rate of formation and degradation of pyroglutamate. Clinica Chimica Acta; International Journal of Clinical Chemistry 49(3): 311-323

Tsuru, D. 1983: Pyroglutamyl peptidase. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 28(12): 1349-1354

Tsuru, D.; Sakabe, K.; Yoshimoto, T.; Fujiwara, K. 1982: Pyroglutamyl peptidase from chicken liver: purification and some properties. Journal of Pharmacobio-Dynamics 5(11): 859-868

Dannies, P.S.; Tashjian, A.H. 1974: Pyroglutamyl-histidyl-prolineamide (TRH). a neurohormone which affects the release and synthesis of prolactin and thyrotropin. Israel Journal of Medical Sciences 10(10): 1294-1304

König, W.; Geiger, R. 1972: Pyroglutamylpeptides. Chemische Berichte 105(9): 2872-2882

Penaud, A.; Nourrit, J.; Timon-David, P.; Autran, P.; Charpin, J. 1971: Pyroglyphid Acari in house dusts. Marseille Medical 108(5): 363-368

Meffert, R.M. 1983: Pyrolite carbon-coated endosseous post-type dental implant. Journal of Oral Implantology 11(1): 36-44

Russo, D.M.; Schneider, H.J. 1981: Pyrolyses products of polyurethane and polyimide foams: effects on unsignalled shock escape behavior. Proceedings of the Western Pharmacology Society 24: 255-258

Gellerman, J.L.; Schlenk, H. 1966: Pyrolysis for structure determination of cyclopropene and cyclopropene fatty acids. Analytical Chemistry 38(1): 72-76

French, G.L.; Gutteridge, C.S.; Phillips, I. 1980: Pyrolysis gas chromatography of Pseudomonas and Acinetobacter species. Journal of Applied Bacteriology 49(3): 505-516

Drucker, D.B.; Gibson, L.F. 1982: Pyrolysis gas chromatography of Streptococcus faecalis: effect of cultural conditions on pyrochromatograms. Microbios 33(132): 93-100

Lloyd, J.B.; Hadley, K.; Roberts, B.R. 1974: Pyrolysis gas chromatography over hydrogenated graphitised carbon black. Differe-tiation of chewing gum bases for forensic purposes. Journal of Chromatography 101(2): 417-423

Cornell, D.; Tsang, W. 1974: Pyrolysis generation of dilute concentration of sulfur dioxide. Analytical Chemistry 46(7): 933-935

Van Haard, P.M.; Hoenders, H.J.; Wollensak, J.; Haverkamp, J. 1980: Pyrolysis mass spectra, sulfhydryl and tryptophan content of the embryonic nuclei from adult human normal and nuclear-cataractous lenses. Biochimica et Biophysica Acta 631(1): 177-187

Posthumus, M.A.; Nibbering, M.M.; Boerboom, A.J.; Schulten, H.R. 1974: Pyrolysis mass spectrometric studies on nucleic acids. Biomedical Mass Spectrometry 1(5): 352-357

Umemoto, S.; Takamatsu, H. 1965: Pyrolysis of (phenylacetyl) carbamates. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 85(10): 879-883

Ning, R.Y.; Sternbach, L.H. 1970: Pyrolysis of 1-adamantyl azidomethyl ketone. Journal of Medicinal Chemistry 13(6): 1251-1252

Popper, T.L.; Gmoj, O.; Carlon, F.E.; Steinberg, M. 1970: Pyrolysis of 16-methylene 17-oxygenated-20-keto steroids. IV. Synthesis of 3-hydroxy-1,3,5(10)-estratrieno[17,16-c]-2'-methylfuran. Journal of Medicinal Chemistry 13(3): 564-565

Popper, T.L.; Carlon, F.E.; Gnoj, O. 1970: Pyrolysis of 17-oxygenated 16-methylene-20-oxosteroids. 3. Preparation and pyrolysis of 17alpha-acetoxy-17beta-methyl-16-methylene-17alpha-oxo-D-homoandrostanes. Journal of the Chemical Society. Perkin Transactions 1 10: 1352-1354

Popper, T.L.; Carlon, F.E.; Gnoj, O. 1970: Pyrolysis of 17-oxygenated 16-methylene-20-oxosteroids. I. Formation of 2'-methylandrostano[17,16-c]furans. Journal of the Chemical Society. Perkin Transactions 1 10: 1344-1349

Popper, T.L.; Gnoj, O. 1970: Pyrolysis of 17-oxygenated 16-methylene-20-oxosteroids. II. Oxidative cleavage of 2'-methylandrostano[17,16-c]furans. Journal of the Chemical Society. Perkin Transactions 1 10: 1349-1351

Nagy, B. 1982: Pyrolysis of Precambrian kerogens: constraints and capabilities. Journal of Molecular Evolution 18(3): 217-220

Ratcliff, M.A.; Medley, E.E.; Simmonds, P.G. 1974: Pyrolysis of amino acids. Mechanistic considerations. Journal of Organic Chemistry 39(11): 1481-1490

Jones, T.C.; Schmeltz, I. 1968: Pyrolysis of caffeic acid, a tobacco leaf constituent. Chemistry and Industry 43: 1480-1481

Möhrle, H.; Kilian, R. 1970: Pyrolysis of esters and aminoxides of phenylethylamine derivatives. Die Pharmazie 25(5): 296-308

Patterson, J.M.; Haidar, N.F.; Papadopoulos, E.P.; Smith, W.T. 1973: Pyrolysis of phenylalanine, 3,6-dibenzyl-2,5-piperazinedione, and phenethylamine. Journal of Organic Chemistry 38(4): 663-666

Chaigneau, M.; Le Moan, G. 1972: Pyrolysis of plastic materials. VI. Polyurethanes. Annales Pharmaceutiques Francaises 30(6): 409-414

Perkins, E.G.; Johnson, P.V. 1969: Pyrolysis-gas chromatography of phosphoglycerides: a mass spectral study of the products. Lipids 4(4): 301-303

Burrows, H.J.; Calam, D.H. 1971: Pyrolysis-gas chromatography of polyene antifungal antibiotics: the nature of candicidin, levorin and trichomycin. Journal of Chromatography 53(3): 566-571

Hall, R.C.; Bennett, G.W. 1973: Pyrolysis-gas chromatography of several cockroach species. Journal of Chromatographic Science 11(8): 439-442

Vincent, P.G.; Kulik, M.M. 1970: Pyrolysis-gas-liquid chromatography of fungi: differentiation of species and strains of several members of the Aspergillus flavus group. Applied Microbiology 20(6): 957-963

Kulik, M.M.; Vincent, P.G. 1973: Pyrolysis-gas-liquid chromatography of fungi: observations on variability among nine Penicillium species of the Section Asymmetrica, Subsection Fasciculata. Mycopathologia et Mycologia Applicata 51(1): 1-18

Sekhon, A.S.; Carmichael, J.W. 1972: Pyrolysis-gas-liquid chromatography of some dermatophytes. Canadian Journal of Microbiology 18(10): 1593-1601

Reiner, E.; Beam, R.E.; Kubica, G.P. 1969: Pyrolysis-gas-liquid chromatography studies for the classification of mycobacteria. American Review of Respiratory Disease 99(5): 750-759

Secchi, L.; Frigerio, A. 1974: Pyrolysis: basic aspects ad some applications. Bollettino Chimico Farmaceutico 113(6): 327-336

Olcott, E.L. 1974: Pyrolytic biocarbon materials. Journal of Biomedical Materials Research 8(3): 209-217

Kent, J.N.; Bokros, J.C. 1980: Pyrolytic carbon and carbon-coated metallic dental implants. Dental Clinics of North America 24(3): 465-485

Hetherington, V.J.; Kavros, S.J.; Conway, F.; Mandracchia, V.J.; Martin, W.; Haubold, A.D. 1982: Pyrolytic carbon as a joint replacement in the foot: a preliminary report. Journal of Foot Surgery 21(3): 160-165

Michieli, S.; Bockros, J.; Haubald, A.; Freeman, S.; Leake, D.; Pizziferrato, A. 1980: Pyrolytic carbon coated metallic implants. Zahnarztliche Praxis 31(11): 492-497; 500-502

Westley, J.W.; Evans, R.H.; Williams, T.; Stempel, A. 1973: Pyrolytic cleavage of antibiotic X-537A and related reactions. Journal of Organic Chemistry 38(19): 3431-3433

McFee, D.R.; Bechtold, R.R. 1971: Pyrolyzer-microcoulomb detector system for measurement of toxicants. American Industrial Hygiene Association Journal 32(11): 766-770

Drogowski, M.; Orlicki, B.; Dawidowski, E. 1966: Pyromania as a symptom of a psycho-organic syndrome in the course of temporal lobe epilepsy. Neurologia Neurochirurgia i Psychiatria Polska 16(12): 1433-1434

Greenberg, H.R. 1966: Pyromania in a woman. Psychoanalytic Quarterly 35(2): 256-262

Medvecký, J.; Marossyová, E. 1970: Pyromania, a case report. Ceskoslovenska Psychiatrie 66(6): 360-363

Hashidoko, Y. 1995: Pyromeconic acid and its glucosidic derivatives from leaves of Erigeron annuus, and the siderophile activity of pyromeconic acid. Bioscience Biotechnology and Biochemistry 59(5): 886-890

Priest, N.D. 1981: Pyronin Y for staining stripped autoradiographs prepared from plastic embedded sections of rat tissues containing plutonium. Stain Technology 56(5): 317-321

Shin, T.S.; Kang, H.S.; Choi, K.D.; Lee, K.S.; Shin, D.C. 1972: Pyroninophilic granules in liver cells of the mice treated with alpha-tocopherol and thioacetamide. Yonsei Medical Journal 13: 40-49

Casey, P.; Russell, R.G.; Fernley, H.N.; Birkett, D.; Bisaz, S.; Fleisch, H. 1967: Pyrophosphatase activity of alkaline phosphatase. Helvetica Physiologica et Pharmacologica Acta 25(2): CR174-CR176

Rozovskaia, T.A.; Chenchik, A.A.; Tarusova, N.B.; Bibilashvili, R.Sh.; Khomutov, R.M. 1981: Pyrophosphate analogs in the pyrophosphorolysis reaction catalyzed by Escherichia coli RNA polymerase. Molekuliarnaia Biologiia 15(6): 1205-1223

Russell, R.G.; Bisaz, S.; Fleisch, H. 1969: Pyrophosphate and diphosphonates in calcium metabolism and their possible role in renal failure. Archives of Internal Medicine 124(5): 571-577

Robotti, C.; Lovisolo, D. 1972: Pyrophosphate and ethylenediaminetetraacetate as relaxants for lower invertebrates prior to fixation. Stain Technology 47(1): 37-38

Draus, F.J.; Lesniewski, M.; Miklos, F.L. 1970: Pyrophosphate and hexametaphosphate effects in in vitro calculus formation. Archives of Oral Biology 15(9): 893-896

Kaplan, G. 1972: Pyrophosphate and its homologs. Role in the phospho-calcic metabolism and bone physiology. Les Cahiers de Medecine 13(1): 13-16

Lewis, A.M.; Thomas, W.C.; Tomita, A. 1966: Pyrophosphate and the mineralizing potential of urine. Clinical Science 30(3): 389-397

Sørensen, K.H.; Teglbjaerg, P.S.; Ladefoged, C.; Christensen, H.E. 1981: Pyrophosphate arthritis with local amyloid deposition. Acta Orthopaedica Scandinavica 52(2): 129-133

Norgaard, O.J. 1973: Pyrophosphate arthritis--a rare condition?. Ugeskrift for Laeger 135(4): 188-191

Currey, H.L. 1970: Pyrophosphate arthropathy and calcific periarthris. Clinical Orthopaedics and Related Research 71: 70-80

Doherty, M.; Dieppe, P.A. 1984: Pyrophosphate arthropathy as a late complication of juvenile chronic arthritis. Journal of Rheumatology 11(2): 219-221

Eade, A.W.; Swannell, A.J.; Williamson, N. 1981: Pyrophosphate arthropathy in hypophosphatasia. Annals of the Rheumatic Diseases 40(2): 164-170

Bourqui, M.; Vischer, T.L.; Stasse, P.; Docquier, C.; Fallet, G.H. 1983: Pyrophosphate arthropathy in the carpal and metacarpophalangeal joints. Annals of the Rheumatic Diseases 42(6): 626-630

Bjelle, A.; Edvinsson, U.; Hagstam, A. 1982: Pyrophosphate arthropathy in two Swedish families. Arthritis and Rheumatism 25(1): 66-74

Doherty, M. 1983: Pyrophosphate arthropathy--recent clinical advances. Annals of the Rheumatic Diseases 42(Suppl 1): 38-44

Dieppe, P.A.; Alexander, G.J.; Jones, H.E.; Doherty, M.; Scott, D.G.; Manhire, A.; Watt, I. 1982: Pyrophosphate arthropathy: a clinical and radiological study of 105 cases. Annals of the Rheumatic Diseases 41(4): 371-376

Bjelle, A.; Sundén, G. 1974: Pyrophosphate arthropathy: a clinical study of fifty cases. Journal of Bone and Joint Surgery. British Volume 56(2): 246-255

Alexander, G.M.; Dieppe, P.A.; Doherty, M.; Scott, D.G. 1982: Pyrophosphate arthropathy: a study of metabolic associations and laboratory data. Annals of the Rheumatic Diseases 41(4): 377-381

Nilsen, T.; Romslo, I. 1984: Pyrophosphate as a ligand for delivery of iron to isolated rat-liver mitochondria. Biochimica et Biophysica Acta 766(1): 233-239

Laszlo, J.; Brown, O.E.; Miller, D.S.; Ove, P. 1969: Pyrophosphate as a selective inhibitor of macromolecule synthesis in normal and leukemic leukocytes. Biochemical Pharmacology 18(6): 1381-1387

Nauss, K.M.; Kitagawa, S.; Gergely, J. 1969: Pyrophosphate binding to and adenosine triphosphatase activity of myosin and its proteolytic fragments. Implications for the substructure of myosin. Journal of Biological Chemistry 244(4): 755-765

Hallson, P.C.; Rose, G.A.; Sulaiman, S. 1983: Pyrophosphate does not influence calcium oxalate or calcium phosphate crystal formation in concentrated whole human urine. Urological Research 11(4): 151-154

Orimo, H.; Fujita, T.; Yoshikawa, M. 1969: Pyrophosphate enhancement of hypocalcemic effect of thyrocalcitonin in rat. Endocrinologia Japonica 16(3): 309-313

Orimo, H.; Fujita, T.; Yoshikawa, M. 1969: Pyrophosphate enhancement of thyrocalcitonin effect in tissue culture. Endocrinologia Japonica 16(4): 415-421

Wong, J.H.; Balogh, A.; Buchanan, B.B. 1984: Pyrophosphate functions as phosphoryl donor with UDP-glucose-treated mammalian phosphofructokinase. Biochemical and Biophysical Research Communications 121(3): 842-847

Duska, F.; Bradna, P.; Novák, J.; Kubícek, J.; Vizda, J.; Kafka, P.; Mazurová, Y.; Blaha, V. 1982: Pyrophosphate heart scan in patients with progressive systemic sclerosis. British Heart Journal 47(1): 90-93

Duska, F.; Vizd'a, J.; Kafka, P.; Kubícek, J.; Simon, J.; Veverková, O.; Bastecký, J. 1980: Pyrophosphate heart scan in the diagnosis of various forms of angina pectoris. Vnitrni Lekarstvi 26(4): 260-266

Bianco, J.A. 1982: Pyrophosphate imaging for infarct sizing. New England Journal of Medicine 306(2): 110

Kent, R.B.; Guterman, S.K. 1982: Pyrophosphate inhibition of rho ATPase: a mechanism of coupling to RNA polymerase activity. Proceedings of the National Academy of Sciences of the United States of America 79(13): 3992-3996

Sommer-Tsilenis, E.; Kallistratos, G.; Timmermann, A. 1967: Pyrophosphate levels of the urine in lithiasis. Münchener Medizinische Wochenschrift 109(6): 293-295

Preiss, J.; Greenberg, E. 1983: Pyrophosphate may be involved in regulation of bacterial glycogen synthesis. Biochemical and Biophysical Research Communications 115(3): 820-826

Lyons, K.P.; Olson, H.G.; Aronow, W.S. 1980: Pyrophosphate myocardial imaging. Seminars in Nuclear Medicine 10(2): 168-177

Duska, F.; Novák, J.; Kubícek, J.; Vizda, J.; Kafka, P.; Blaha, V.; Nesvadba, Z.; Zdánský, P. 1982: Pyrophosphate scan of the heart in cardiomyopathies. Ceskoslovenska Radiologie 36(1): 40-47

Duska, F.; Novák, J.; Vizda, J.; Kubícek, J.; Kafka, P.; Veverková, O. 1981: Pyrophosphate scan of the temporarily ischemized dog myocardium. Nuklearmedizin. Nuclear Medicine 20(6): 268-271

Purdue, G.F.; Lewis, S.A.; Hunt, J.L. 1983: Pyrophosphate scanning in early frostbite injury. American Surgeon 49(11): 619-620

Duska, F.; Novák, J.; Vizda, J.; Kubícek, J.; Kafka, P. 1980: Pyrophosphate scintigraphy of the myocardium after cardioversion. Vnitrni Lekarstvi 26(7): 635-641

Popa, N.; Dupont, J.C.; Alsteens, G.; Pahaut, P.; Huysmans, P.; Berger, S. 1981: Pyrophosphate scintigraphy: improved detection of the acute myocardial infarction with computer data manipulation and Fourier method analysis. International Journal of Nuclear Medicine and Biology 8(2-3): 189-198

Anderson, H.C.; Reynolds, J.J. 1973: Pyrophosphate stimulation of calcium uptake into cultured embryonic bones. Fine structure of matrix vesicles and their role in calcification. Developmental Biology 34(2): 211-227

Bjelle, A.; Sundén, G. 1971: Pyrophosphate synovitis. Crystal synovitis caused by calcium pyrophosphatedihydrate (CPPD) as a diagnostic problem in orthopedic patients. Acta Orthopaedica Scandinavica 42(2): 131-141

Cheng, P.T.; Pritzker, K.P. 1983: Pyrophosphate, phosphate ion interaction: effects on calcium pyrophosphate and calcium hydroxyapatite crystal formation in aqueous solutions. Journal of Rheumatology 10(5): 769-777

Russell, R.G.; Fleisch, H. 1970: Pyrophosphate, phosphonates and pyrophosphatases in the regulation of calcification and calcium homeostasis. Proceedings of the Royal Society of Medicine 63(9): 876

Artiushkin, A.V.; Kanaev, V.; Malinin, A.P.; Volkov, A.A. 1980: Pyrophosphate-99mTc scintigraphy in detecting bone lesions and controlling therapy effectiveness in lymphogranulomatosis. Meditsinskaia Radiologiia 25(6): 27-31

Vinogradov, A.V.; Sycheva, I.M.; Rylova, A.K.; Gel'fand, I.N.; Lobzeva, V.I. 1980: Pyrophosphate-99mTc scintigraphy in stenocardia patients. Kardiologiia 20(5): 26-29

Pfleiderer, C.; Klemme, J.H. 1980: Pyrophosphate-dependent D-fructose-6-phosphate-phosphotransferase in Rhodospirillaceae. Zeitschrift für Naturforschung. Section C Biosciences 35(3-4): 229-238

Reeves, R.E.; South, D.J.; Blytt, H.J.; Warren, L.G. 1974: Pyrophosphate:D-fructose 6-phosphate 1-phosphotransferase. a new enzyme with the glycolytic function of 6-phosphofructokinase. Journal of Biological Chemistry 249(24): 7737-7741

Lam, K.S.; Kasper, C.B. 1980: Pyrophosphate:protein phosphotransferase: a membrane-bound enzyme of endoplasmic reticulum. Proceedings of the National Academy of Sciences of the United States of America 77(4): 1927-1931

Ito, T.; Kaneko, H. 1974: Pyrophosphatidic acid. a new phospholipid from cryptococcus neoformans. Journal of Biochemistry 75(6): 1291-1300

Ivoclar, A.G. 1966: Pyroplast SR--a new resin for crown and bridge technic. Annales Pharmaceutiques Francaises 24(5): 42-44

Schmitt, W.M. 1967: Pyroplast technic. Der Kassenzahnarzt; Colloquium Med. Dent 39: 9-10

Dumont, M.; Bouvier, J. 1966: Pyrosis and heartburn in pregnant women. Revue Francaise de Gynecologie et d'Obstetrique 61(7): 593-607

Reisfield, D.R. 1971: Pyrosis and pregnancy. Current Therapeutic Research 13(11): 680-684

Secchi, G.C.; Negri, E.; Monti, M.A.; Bertazzi, P.A.; Zocchetti, C. 1984: Pyrosis in major diseases of the upper digestive tract. Computerized analysis of symptoms in 700 cases subjected to gastroduodenoscopy. Minerva Medica 75(40): 2333-2344

Aoyama, T.; Kojima, F.; Imada, C.; Muraoka, Y.; Naganawa, H.; Okami, Y.; Takeuchi, T.; Aoyagi, T. 1995: Pyrostatins A and B, new inhibitors of N-acetyl-beta-D-glucosaminidase, produced by Streptomyces sp. SA-3501. Journal of Enzyme Inhibition 8(4): 223-232

Patshikh, E.V. 1966: Pyrotherapy (review). Vestnik Oftalmologii 79(5): 86-88

Petrusek, R.L.; Anderson, G.L.; Garner, T.F.; Fannin, Q.L.; Kaplan, D.J.; Zimmer, S.G.; Hurley, L.H. 1981: Pyrrol[1,4]benzodiazepine antibiotics. Proposed structures and characteristics of the in vitro deoxyribonucleic acid adducts of anthramycin, tomaymycin, sibiromycin, and neothramycins A and B. Biochemistry 20(5): 1111-1119

Zeile, K.; Hübner, H.H. 1965: Pyrrole and pyrrolidine derivatives as primers in the synthesis of tropinone. Enzymologia 29(3): 114-120

Bailey, D.M.; Johnson, R.E.; Salvador, U.J. 1973: Pyrrole antibacterial agents. 1. Compounds related to pyoluteorin. Journal of Medicinal Chemistry 16(11): 1298-1300

Martin, R.B. 1974: Pyrrole hydrogen ionization of imidazole derivatives in metal ion complexes and carbonic anhydrase. Proceedings of the National Academy of Sciences of the United States of America 71(11): 4346-4347

Kreimer-Birnbaum, M.; Bannerman, R.M.; Russell, E.S.; Bernstein, S.E. 1972: Pyrrole pigments in normal and congenitally anaemic mice (+:+, W-W v , ha-ha, nb-nb, mk-mk, f-f and sla-Y). Comparative Biochemistry and Physiology. a Comparative Physiology 43(1): 21-30

Zawirska, B.; Medraś, K.; Sośnik, H. 1971: Pyrrole pigments of organs during 2-amino-N-acetylfluorene-induced carcinogenesis in rats. Zentralblatt für Allgemeine Pathologie U. Pathologische Anatomie 114(1): 41-50

Crook, P.J.; Jackson, A.H.; Kenner, G.W. 1971: Pyrroles and related compounds. 18. Synthesis of alpha-oxy-mesoporphyrine IX. Justus Liebigs Annalen der Chemie 748: 26-37

Jackson, A.H.; Kenner, G.W.; Wass, J. 1974: Pyrroles and related compounds. 25. Pemptoporphyrin, iso-pemptoporphyrin, and chlorocruoroporphyrin (Spirographis porphyrin). Journal of the Chemical Society. Perkin Transactions 1 4: 480-490

Howarth, T.T.; Jackson, A.H.; Judge, J.; Kenner, G.W. 1974: Pyrroles and related compounds. 26. Pyrrole beta-keto-esters. Journal of the Chemical Society. Perkin Transactions 1 4: 490-501

Howarth, T.T.; Jackson, A.H.; Kenner, G.W. 1974: Pyrroles and related compounds. 27. Syntheses of porphyrins with a nuclear carboxy-group. Journal of the Chemical Society. Perkin Transactions 1 4: 502-511

Cox, M.T.; Howarth, T.T.; Jackson, A.H.; Kenner, G.W. 1974: Pyrroles and related compounds. 28. Beta-keto-esters in the porphyrin series. Journal of the Chemical Society. Perkin Transactions 1 4: 512-516

Cox, M.T.; Jackson, A.H.; Kenner, G.W.; McCombie, S.W.; Smith, K.M. 1974: Pyrroles and related compounds. 29. Vinylporphyrin beta-keto-esters. Journal of the Chemical Society. Perkin Transactions 1 4: 516-527

Kenner, G.W.; McCombie, S.W.; Smith, K.M. 1974: Pyrroles and related compounds. 30. Cyclisation of porphyrin beta-keto-esters to phaeoporphyrins. Journal of the Chemical Society. Perkin Transactions 1 4: 527-530

Jones, R.V.; Kenner, G.W.; Smith, K.M. 1974: Pyrroles and related compounds. 31. Porphyrin ketones. Journal of the Chemical Society. Perkin Transactions 1 4: 531-534

Cavaleiro, J.A.; Rocha Gonsalves, A.M.; Kenner, G.W.; Smith, K.M. 1974: Pyrroles and related compounds. 33. Total synthesis of deuteriated derivatives of protoporphyrin-IX for nuclear magnetic resonance studies of haemoproteins. Journal of the Chemical Society. Perkin Transactions 15: 1771-1781

Jackson, A.H.; Kenner, G.W.; Wass, J. 1972: Pyrroles and related compounds. XX. Syntheses of coproporphyrins. Journal of the Chemical Society. Perkin Transactions 1 12: 1475-1483

Cavaleiro, J.A.; Kenner, G.W.; Smith, K.M. 1974: Pyrroles and related compounds. XXXII. Biosynthesis of protoporphyrin-IX from coproporphyrinogen-3. Journal of the Chemical Society. Perkin Transactions 10: 1188-1194

Frydman, B.; Reil, S.; Despuy, M.E.; Rapoport, H. 1969: Pyrroles from azaindoles. a synthesis of porphobilinogen and related pyrroles. Journal of the American Chemical Society 91(9): 2338-2342

Mattocks, A.R.; Bird, I. 1983: Pyrrolic and N-oxide metabolites formed from pyrrolizidine alkaloids by hepatic microsomes in vitro: relevance to in vivo hepatotoxicity. Chemico-Biological Interactions 43(2): 209-222

Lotti, B.; Vezzosi, O. 1972: Pyrrolic derivatives with hypoglycemic activity. Il Farmaco; Edizione Scientifica 27(4): 317-321

Moav, B.; Harris, T.N. 1967: Pyrrolid-2-one-5 carboxylic acid involvement in the biosynthesis of rabbit immunoglobulin. Biochemical and Biophysical Research Communications 29(5): 773-776

O'Donnell, I.J. 1968: Pyrrolid-2-one-5-carboxylic acid as an N-terminal group of the low-sulphur proteins of wool. Australian Journal of Biological Sciences 21(6): 1327-1330

Andersson, B.A.; Holman, R.T. 1974: Pyrrolidides for mass spectrometric determination of the position of the double bond in monounsaturated fatty acids. Lipids 9(3): 185-190

Orthner, C.L.; Rodgers, G.M.; Fitzgerald, L.A. 1995: Pyrrolidine dithiocarbamate abrogates tissue factor (TF) expression by endothelial cells: evidence implicating nuclear factor-kappa B in TF induction by diverse agonists. Blood 86(2): 436-443

Eberhardt, W.; Kunz, D.; Pfeilschifter, J. 1994: Pyrrolidine dithiocarbamate differentially affects interleukin 1 beta- and cAMP-induced nitric oxide synthase expression in rat renal mesangial cells. Biochemical and Biophysical Research Communications 200(1): 163-170

Bedoya, F.J.; Flodström, M.; Eizirik, D.L. 1995: Pyrrolidine dithiocarbamate prevents IL-1-induced nitric oxide synthase mRNA, but not superoxide dismutase mRNA, in insulin producing cells. Biochemical and Biophysical Research Communications 210(3): 816-822

Shekar, S.C.; Sankaram, M.B.; Easwaran, K.R. 1984: Pyrrolidine ring conformations in prolyl peptides from 13C spin-lattice relaxation times. International Journal of Peptide and Protein Research 23(2): 166-173

Reist, E.J.; Fisher, L.V.; Goodman, L. 1967: Pyrrolidine sugars. Synthesis of 9-(4-acetamido-4-deoxy-beta-D-xylofuranosyl)adenine and other derivatives of 4-amino-4-deoxy-D-xylose. Journal of Organic Chemistry 32(8): 2541-2544

Böhme, H.; Sitorus, U. 1974: Pyrrolidine-3 and pyrazoline-4-spiro-1'-isothiochromanes and -isochromanes. 12. Studies on the isochromane- and isothiochromane series. Archiv der Pharmazie 307(1): 27-30

Muftic, M. 1968: Pyrrolidine-N-carboxylic acid-3-methyl-5-isopropylphenyl ester, a new specific antidermatophytal agent. Mykosen 11(5): 369-376

Hankins, W.; Burger, A. 1970: Pyrrolidine-substituted nicotine analogs: synthesis and pharmacology. Journal of Pharmaceutical Sciences 59(3): 342-344

Bezante, T. 1966: Pyrrolidino-methyl-tetracycline. on its use in early childhood. Minerva Pediatrica 18(26): 1435-1438

Khare, B.B. 1967: Pyrrolidinomethyltetracycline in cavernous sinus thrombosis. British Journal of Ophthalmology 51(10): 712-713

Fragale, A.; Vellucci, A. 1965: Pyrrolidinomethyltetracycline. (Study of liver function during its clinical use). Epatologia 11(6): 505-518

Wolfersberger, M.G.; Tabachnik, J. 1973: Pyrrolidone carboxylic acid (pyroglutamic acid) in normal plasma. Experientia 29(3): 346-347

Barrett, J.G.; Scott, I.R. 1983: Pyrrolidone carboxylic acid synthesis in guinea pig epidermis. Journal of Investigative Dermatology 81(2): 122-124

Goodman, J.W.; Klaus, G.G.; Nitecki, D.E.; Wang, A.C. 1970: Pyrrolidonecarboxylic acid at the N-terminal positions of polypeptide chains from leopard shark immunoglobulins. Journal of Immunology 104(1): 260-262

Woodley, J.F. 1972: Pyrrolidonecarboxylyl peptidase activity in normal intestinal biopsies and those from coeliac patients. Clinica Chimica Acta; International Journal of Clinical Chemistry 42(1): 211-213

Armentrout, R.W. 1969: Pyrrolidonecarboxylyl peptidase from rat liver. Biochimica et Biophysica Acta 191(3): 756-759

Armentrout, R.W.; Doolittle, R.F. 1969: Pyrrolidonecarboxylyl peptidase: stabilization and purification. Archives of Biochemistry and Biophysics 132(1): 80-90

Uliana, J.A.; Doolittle, R.F. 1969: Pyrrolidonecarboxylyl peptidase: studies on the specificity of the enzyme. Archives of Biochemistry and Biophysics 131(2): 561-565

Heimrath, T. 1973: Pyrrolidonyl peptidase (PLP) in females. its activity in serum, urine, milk and placenta. Polski Tygodnik Lekarski 28(49): 1924-1927

Szewczuk, A.; Mulczyk, M. 1969: Pyrrolidonyl peptidase in bacteria. the enzyme from Bacillus subtilis. European Journal of Biochemistry 8(1): 63-67

Fleming, G.A.; Hagedorn, C.H.; Granger, A.S.; Phang, J.M. 1984: Pyrroline-5-carboxylate in human plasma. Metabolism, Clinical and Experimental 33(8): 739-742

Yeh, G.C.; Harris, S.C.; Phang, J.M. 1981: Pyrroline-5-carboxylate reductase in human erythrocytes. Journal of Clinical Investigation 67(4): 1042-1046

Smith, R.J.; Downing, S.J.; Phang, J.M.; Lodato, R.F.; Aoki, T.T. 1980: Pyrroline-5-carboxylate synthase activity in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America 77(9): 5221-5225

Wakabayashi, Y.; Jones, M.E. 1983: Pyrroline-5-carboxylate synthesis from glutamate by rat intestinal mucosa. Journal of Biological Chemistry 258(6): 3865-3872

Wakabayashi, Y.; Henslee, J.G.; Jones, M.E. 1983: Pyrroline-5-carboxylate synthesis from glutamate by rat intestinal mucosa. Subcellular localization and temperature stability. Journal of Biological Chemistry 258(6): 3873-3882

Callery, P.S.; Geelhaar, L.A.; Nayar, M.S.; Stogniew, M.; Rao, K.G. 1982: Pyrrolines as prodrugs of gamma-aminobutyric acid analogues. Journal of Neurochemistry 38(4): 1063-1067

Davies, N.M.; Crout, D.H. 1974: Pyrrolizidine alkaloid biosynthesis. Relative rates of incorporation of the isomers of isoleucine into the necic acid component of senecionine. Journal of the Chemical Society. Perkin Transactions 18: 2079-2082

Williams, D.E.; Miranda, C.L.; Buhler, D.R. 1983: Pyrrolizidine alkaloid-induced alterations in benzo[alpha]pyrene metabolism and binding of benzo[alpha]pyrene metabolites to deoxyribonucleic acid. Biochemical Pharmacology 32(16): 2443-2447

Anonymous 1971: Pyrrolizidine alkaloids and metabolic pyrroles. Food and Cosmetics Toxicology 9(6): 893-896

Lüthy, J.; Brauchli, J.; Zweifel, U.; Schmid, P.; Schlatter, C. 1984: Pyrrolizidine alkaloids in medicinal plants of Boraginaceal: Borago officinalis L. and Pulmonaria officinalis L. Pharmaceutica Acta Helvetiae 59(9-10): 242-246

Anonymous 1972: Pyrrolizidine alkaloids--the importance of being metabolized. Food and Cosmetics Toxicology 10(6): 873-874

Crout, D.H. 1967: Pyrrolizidine alkaloids. Biosynthesis of the angelate component of heliosupine. Journal of the Chemical Society. Perkin Transactions 1 13: 1233-1234

Pomeroy, A.R.; Raper, C. 1971: Pyrrolizidine alkaloids: actions on muscarinic receptors in the guinea-pig ileum. British Journal of Pharmacology 41(4): 683-690

Pomeroy, A.R.; Raper, C. 1972: Pyrrolizidine alkaloids: analysis of spasmolytic activity in the guinea-pig ileum. Archives Internationales de Pharmacodynamie et de Therapie 199(1): 5-15

Pomeroy, A.R.; Raper, C. 1971: Pyrrolizidine aminoalcohols: indirect cholinomimetic activity in guinea-pig ileum. European Journal of Pharmacology 14(4): 374-383

Cecchi, L.; Melani, F.; Palazzino, G.; Filacchioni, G.; Porretta, G.C. 1984: Pyrrolnitrin analogues. IX. Synthesis and biological activity of 1-tolyl-3-nitrophenyl-5-methylpyrazole-4-carboxylic acids and 1-tolyl-3-methyl-5-nitrophenylpyrazole-4-carboxylic acids. Il Farmaco; Edizione Scientifica 39(10): 888-900

Filacchioni, G.; Porretta, G.C.; Scalzo, M.; Giardina, M.C.; Giardi, T. 1983: Pyrrolnitrin analogues. VIII - Synthesis and antibacterial activity of new 1,4- and 1,5-diarylpyrroles. Il Farmaco; Edizione Scientifica 38(9): 630-639

Cecchi, L.; Melani, F.; Palazzino, G.; Filacchioni, G. 1984: Pyrrolnitrin analogues. X. Synthesis and biological activity of 1-chlorophenyl-3- or 5-nitrophenyl-pyrazole-4-carboxylic acids. Il Farmaco; Edizione Scientifica 39(11): 953-962

Eiden, F.; Bachmann, G. 1973: Pyrrolo (1,2-a) quinoxalines. Archiv der Pharmazie 306(11): 876-879

Hammer, R.H. 1968: Pyrrolo [2,3-d] pyrimidines. Journal of Pharmaceutical Sciences 57(9): 1616-1619

Demerson, C.A.; Philipp, A.H.; Humber, L.G.; Kraml, M.J.; Charest, M.P.; Tom, H.; Vávra, I. 1974: Pyrrolo(4,3,2-de)isoquinolines with central nervous system and antihypertensive activities. Journal of Medicinal Chemistry 17(11): 1140-1145

Maggi, N.; Arioli, V.; Tamborini, G. 1969: Pyrrolo-rifamycin: synthesis and antibacterial properties. Il Farmaco; Edizione Scientifica 24(3): 263-275

Schulz, W.G.; Islam, I.; Skibo, E.B. 1995: Pyrrolo[1,2-a]benzimidazole-based quinones and iminoquinones. the role of the 3-substituent on cytotoxicity. Journal of Medicinal Chemistry 38(1): 109-118

Franck, R.W.; Bernady, K.F. 1968: Pyrrolo[1,2-alpha]indole chemistry. Reactions of a tridentate carbanion. Journal of Organic Chemistry 33(8): 3050-3055

Campiani, G.; Garofalo, A.; Fiorini, I.; Botta, M.; Nacci, V.; Tafi, A.; Chiarini, A.; Budriesi, R.; Bruni, G.; Romeo, M.R. 1995: Pyrrolo[2,1-c][1,4]benzothiazines: synthesis, structure-activity relationships, molecular modeling studies, and cardiovascular activity. Journal of Medicinal Chemistry 38(22): 4393-4410

Tolman, R.L.; Robins, R.K.; Townsend, L.B. 1968: Pyrrolo[2,3-d]pyrimidine nucleoside antibiotics. Total synthesis and structure of toyocamycin, unamycin B, vengicide, antibiotic E-212, and Sangivamycin (BA-90912). Journal of the American Chemical Society 90(2): 524-526

Hester, J.B.; Rudzik, A.D.; Veldkamp, W. 1970: Pyrrolo[3,2,1-jk][1,4]benzodiazepines and pyrrolo[1,2,3-ef][1,5]benzodiazepines which have central nervous system activity. Journal of Medicinal Chemistry 13(5): 827-835

Maryanoff, B.E.; McComsey, D.F.; Castanzo, M.J.; Setler, P.E.; Gardocki, J.F.; Shank, R.P.; Schneider, C.R. 1984: Pyrroloisoquinoline antidepressants. Potent, enantioselective inhibition of tetrabenazine-induced ptosis and neuronal uptake of norepinephrine, dopamine, and serotonin. Journal of Medicinal Chemistry 27(8): 943-946

Ezaki, N.; Koyama, M.; Kodama, Y.; Shomura, T.; Tashiro, K.; Tsuruoka, T.; Inouye, S.; Sakai, S. 1983: Pyrrolomycins F1, F2a, F2b and F3, new metabolites produced by the addition of bromide to the fermentation. Journal of Antibiotics 36(11): 1431-1438

Frydman, R.B.; Tomaro, M.L.; Frydman, B. 1972: Pyrrolooxygenase: its action on tryptophan-containing enzymes and peptides. Biochimica et Biophysica Acta 284(1): 80-89

Frydman, B.; Frydman, R.B.; Tomaro, M.L. 1973: Pyrrolooxygenases: a new type of oxidases. Molecular and Cellular Biochemistry 2(2): 121-136

Frydman, R.B.; Tomaro, M.L.; Frydman, B. 1972: Pyrrolooxygenases: isolation, properties, and products formed. Biochimica et Biophysica Acta 284(1): 63-79

Scott, R.D.; Ueno, H.; Metzler, D.E. 1982: Pyrrolopyridine derivatives from pyridoxal 5'-sulfate. Biochemistry 21(21): 5213-5219

Ritch, P.S.; Helmsworth, M. 1982: Pyrrolopyrimidine lethality in relation to ribonucleic acid synthesis in sarcoma 180 cells in vitro. Biochemical Pharmacology 31(16): 2686-2688

Maruyama, T.; Wotring, L.L.; Townsend, L.B. 1983: Pyrrolopyrimidine nucleosides. 18. Synthesis and chemotherapeutic activity of 4-amino-7-(3-deoxy-beta-D-ribofuranosyl)pyrrolo[2,3-d] pyrimidine-5-carboxamide (3'-deoxysangivamycin) and 4-amino-7-(2-deoxy-beta-D-ribofuranosyl)pyrrolo[2,3-d] pyrimidine-5-carboxamide (2'-deoxysangivamycin). Journal of Medicinal Chemistry 26(1): 25-29

Tolman, R.L.; Robins, R.K.; Townsend, L.B. 1969: Pyrrolopyrimidine nucleosides. 3. the total synthesis of toyocamycin, sangivamycin, tubercidin, and related derivatives. Journal of the American Chemical Society 91(8): 2102-2108

Hinshaw, B.C.; Gerster, J.F.; Robins, R.K.; Townsend, L.B. 1970: Pyrrolopyrimidine nucleosides. V. a study on the relative chemical reactivity of the 5-cyano group of the nucleoside antibiotic toyocamycin and desaminotoyocamycin. the synthesis of analogs of sangivamycin. Journal of Organic Chemistry 35(1): 236-241

Alekseev, V.S.; Cherniaeva, A.M. 1966: Pyrrolysidine alkaloid khastatsin from Cacalia robusta Tolm. Farmatsevtychnyi Zhurnal 21(6): 40

Kuzin, M.I.; Prianishnikova, N.T.; Osipova, N.A.; Khadzhieva, S.N.; Guznov, G.I. 1970: Pyrromecaine anesthesia during instrumental diagnostic studies in patients with lung diseases. Khirurgiia 46(6): 58-62

Seliuzhitskiĭ, N.S. 1982: Pyrroxan and clofelin effectiveness in hypertensive crises. Vrachebnoe Delo 6: 57-59

Vorob'ev, S.P.; Gromov, S.A.; Starykh, N.T. 1973: Pyrroxan therapy of patients with diencephalic epilepsy. Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 73(11): 1732-1735

Stella, A.M.; Parera, V.E.; Llambías, E.B.; Batlle, A.M. 1971: Pyrrylmethane intermediates in the synthesis of uroporphyrinogen 3 by soybean callus porphobilinogenase. Biochimica et Biophysica Acta 252(3): 481-488

Owen, T.C.; Young, P.R. 1974: Pyruvamide-promoted deamination and decarboxylation of amines and amino acids: a system modelling histidine decarboxylase. Febs Letters 43(3): 308-312

Webb, M. 1968: Pyruvate accumulation in growth-inhibited cultures of Aerobacter aerogenes. Biochemical Journal 106(2): 375-380

Laursen, A.B. 1973: Pyruvate and citrate concentrations in rabbit aqueous humour determined by an enzymatic procedure. Acta Ophthalmologica 51(5): 700-709

Pope, N.R.; Cole, J.A. 1984: Pyruvate and ethanol as electron donors for nitrite reduction by Escherichia coli K12. Journal of General Microbiology 130(5): 1279-1284

Kozlova, N.M.; Slobozhanina, E.I.; Chernitskiĭ, E.A.; Vadetskaia, T.N.; Vorontsova, T.V. 1983: Pyruvate and glucose transport through the erythrocyte membranes and the role of spectrin in these processes. Biofizika 28(5): 826-829

Vivarelli, E.; Stefanini, M.; Siracusa, G. 1984: Pyruvate and lactate production by cultured Sertoli cells, fibroblasts and muscle satellite cells, and the effect of hormonal and dcAMP stimulation. Cell Biology International Reports 8(9): 739-746

Harris, M. 1980: Pyruvate blocks expression of sensitivity to antimycin a and chloramphenicol. Somatic Cell Genetics 6(6): 699-708

Hansen, T.L.; Christensen, E. 1980: Pyruvate carboxylase activity in amniotic fluid cells. Pediatric Research 14(12): 1412-1413

Takada, G.; Ohtake, M.; Miyabayashi, S.; Narisawa, K.; Tada, K. 1982: Pyruvate carboxylase activity in lymphoblasts. Journal of Inherited Metabolic Disease 5(2): 69-70

Yu, A.C.; Drejer, J.; Hertz, L.; Schousboe, A. 1983: Pyruvate carboxylase activity in primary cultures of astrocytes and neurons. Journal of Neurochemistry 41(5): 1484-1487

Dijkstra, U.J.; Trijbels, J.M.; Ruitenbeek, W.; Bakkeren, J.A.; Janssen, A.J.; Gabreëls, F.J.; Joosten, E.M. 1984: Pyruvate carboxylase activity is not abnormal in fibroblasts of patients with Friedreich's ataxia. Annals of Neurology 16(2): 262

Anderson, J.W. 1970: Pyruvate carboxylase and phosphoenolpyruvate carboxykinase in rat intestinal mucosa. Biochimica et Biophysica Acta 208(1): 165-167

Davis, E.J.; Spydevold, O.; Bremer, J. 1980: Pyruvate carboxylase and propionyl-CoA carboxylase as anaplerotic enzymes in skeletal muscle mitochondria. European Journal of Biochemistry 110(1): 255-262

Palacian, E.; Neet, K.E. 1974: Pyruvate carboxylase cold inactivation and sulfhydryl groups. Molecular and Cellular Biochemistry 3(1): 35-38

Bartlett, K.; Ghneim, H.K.; Stirk, J.H.; Dale, G.; Alberti, K.G. 1984: Pyruvate carboxylase deficiency. Journal of Inherited Metabolic Disease 7 Suppl. 1: 74-78

Phibbs, P.V.; Feary, T.W.; Blevins, W.T. 1974: Pyruvate carboxylase deficiency in pleiotropic carbohydrate-negative mutant strains of Pseudomonas aeruginosa. Journal of Bacteriology 118(3): 999-1009

Scrutton, M.C.; Young, M.R.; Utter, M.F. 1970: Pyruvate carboxylase from baker's yeast. the presence of bound zinc. Journal of Biological Chemistry 245(22): 6220-6227

Barden, R.E.; Scrutton, M.C. 1974: Pyruvate carboxylase from chicken liver. Effects of univalent and divalent cations on catalytic activity. Journal of Biological Chemistry 249(15): 4829-4838

Reed, G.H.; Scrutton, M.C. 1974: Pyruvate carboxylase from chicken liver. Magnetic resonance studies of the effect of substrates and inhibitors on the environment of the bound manganese. Journal of Biological Chemistry 249(19): 6156-6162

Barden, R.E.; Fung, C.H.; Utter, M.F.; Scrutton, M.C. 1972: Pyruvate carboxylase from chicken liver. Steady state kinetic studies indicate a "two-site" ping-pong mechanism. Journal of Biological Chemistry 247(4): 1323-1333

Scrutton, M.C.; White, M.D. 1972: Pyruvate carboxylase from rat liver: catalytic properties in the absence, and at low concentrations, of acetyl-CoA. Biochemical and Biophysical Research Communications 48(1): 85-93

Payne, J.; Morris, J.G. 1969: Pyruvate carboxylase in Rhodopseudomonas spheroides. Journal of General Microbiology 59(1): 97-101

Delvin, E.; Scriver, C.R.; Neal, J.L. 1974: Pyruvate carboxylase in human liver. Apparent loss of a component of catalytic activity in a form of lactic acidosis with hypoglycemia. Biochemical Medicine 10(2): 97-106

Gul, B.; Dils, R. 1968: Pyruvate carboxylase in lactating rat and rabbit mammary gland. Biochemical Journal 109(3): 26p-27p

Feir, H.A.; Suzuki, I. 1969: Pyruvate carboxylase of Aspergillus niger: kinetic study of a biotin-containing carboxylase. Canadian Journal of Biochemistry 47(7): 697-710

Ramírez, A.; Eyzaguirre, J. 1973: Pyruvate carboxylase of Pseudomonas aeruginosa. Purification and properties. Archivos de Biologia y Medicina Experimentales 9(1,2,3): 20-28

Rinaudo, M.T.; Giunta, C. 1967: Pyruvate carboxylase, malate dehydrogenase, fumarase and glutamic-oxalacetic transaminase in the soluble and mitochondrial fraction of the liver of the Gallus domesticus embryo during development. Bollettino della Societa Italiana di Biologia Sperimentale 43(7): 351-352

Palacián, E.; Neet, K.E. 1970: Pyruvate carboxylase. Effect of the chemical modification of the sulfhydryl groups on the activity and quaternary structure. Biochimica et Biophysica Acta 212(1): 158-169

Scrutton, M.C.; White, M.D. 1974: Pyruvate carboxylase. Inhibition of the mammalian and avian liver enzymes by alpha-ketoglutarate and L-glutamate. Journal of Biological Chemistry 249(17): 5405-5415

Scrutton, M.C.; White, M.D. 1973: Pyruvate carboxylase. Specific inactivation of acetyl coenzyme A-dependent oxylacetate synthesis during modification of the enzyme by trinitrobenzene sulfonate. Journal of Biological Chemistry 248(15): 5541-5544

Scrutton, M.C. 1974: Pyruvate carboxylase. Studies of activator-independent catalysis and of the specificity of activation by acyl derivatives of coenzyme a for the enzyme from rat liver. Journal of Biological Chemistry 249(22): 7057-7067

Mildvan, A.S.; Scrutton, M.C.; Utter, M.F. 1966: Pyruvate carboxylase. VII. a possible role for tightly bound manganese. Journal of Biological Chemistry 241(15): 3488-3498

Scrutton, M.C.; Mildvan, A.S. 1968: Pyruvate carboxylase. XI. Nuclear magnetic resonance studies of the properties of the bound manganese after interaction of the biotin residues with avidin. Biochemistry 7(4): 1490-1505

Palacián, E.; Neet, K.E. 1972: Pyruvate carboxylase: inactivation by sulfhydryl-group reagents in the presence of certain inorganic anions, substrates, and modifiers and the effects on the allosteric properties of the enzyme. Biochimica et Biophysica Acta 276(1): 297-312

Scrutton, M.C.; Mildvan, A.S. 1970: Pyruvate carboxylase: nuclear magnetic resonance studies of the enzyme-manganese-oxalacetate and enzyme-manganese-pyruvate bridge complexes. Archives of Biochemistry and Biophysics 140(1): 131-151

Ohtake, M.; Takada, G.; Miyabayashi, S.; Arai, N.; Tada, K.; Morinaga, S. 1982: Pyruvate decarboxylase deficiency in a patient with Leigh's encephalomyelopathy. Tohoku Journal of Experimental Medicine 137(4): 379-386

Evans, O.B. 1981: Pyruvate decarboxylase deficiency in subacute necrotizing encephalomyelopathy. Archives of Neurology 38(8): 515-519

Oba, K.; Uritani, I. 1982: Pyruvate decarboxylase from sweet potato roots. Methods in Enzymology 90 Pt E: 528-532

Gounaris, A.D.; Turkenkopf, I.; Buckwald, S.; Young, A. 1971: Pyruvate decarboxylase. I. Protein dissociation into subunits under conditions in which thiamine pyrophosphate is released. Journal of Biological Chemistry 246(5): 1302-1309

Krampitz, G.; Hardebeck, H. 1966: Pyruvate degradation in aqueous solution accelerated by thermal proteinoids. Die Naturwissenschaften 53(3): 81-82

Ostrovskiĭ, I.M.; Makarina-Kibak, L.I. 1967: Pyruvate dehydrogenase activity following introduction of excessive thiamine into the body. Biulleten' Eksperimental'noi Biologii i Meditsiny 63(5): 54-55

Knowles, S.E.; Ballard, F.J. 1974: Pyruvate dehydrogenase activity in rat liver during development. Biology of the Neonate 24(1): 41-48

Butterworth, R.F.; Giguère, J.F. 1984: Pyruvate dehydrogenase activity in regions of the rat brain during postnatal development. Journal of Neurochemistry 43(1): 280-282

Kustermann-Kuhn, B.; Harzer, K.; Schröder, R.; Permanetter, W.; Peiffer, J. 1984: Pyruvate dehydrogenase activity is not deficient in the brain of three autopsied cases with Leigh disease (subacute necrotizing encephalomyelopathy, SNE). Human Genetics 68(1): 51-53

Hemalatha, S.G.; Kerr, D.S.; Wexler, I.D.; Lusk, M.M.; Kaung, M.; Du, Y.; Kolli, M.; Schelper, R.L.; Patel, M.S. 1995: Pyruvate dehydrogenase complex deficiency due to a point mutation (P188L) within the thiamine pyrophosphate binding loop of the E1 alpha subunit. Human Molecular Genetics 4(2): 315-318

Harada, T.; Hirabayashi, T. 1982: Pyruvate dehydrogenase complex from Hansenula. Methods in Enzymology 89 Pt D: 420-423

Harding, R.W.; Caroline, D.F.; Wagner, R.P. 1982: Pyruvate dehydrogenase complex from Neurospora. Methods in Enzymology 89 Pt D: 386-391

Strumilo, S.A.; Senkevich, S.B.; Vinogradov, V.V. 1983: Pyruvate dehydrogenase complex in the rabbit adrenal glands: activation by administration of ACTH. Problemy Endokrinologii 29(6): 59-63

Diaz, F.; Komuniecki, R.W. 1994: Pyruvate dehydrogenase complexes from the equine nematode, Parascaris equorum, and the canine cestode, Dipylidium caninum, helminths exhibiting anaerobic mitochondrial metabolism. Molecular and Biochemical Parasitology 67(2): 289-299

Saumweber, H.; Binder, R.; Bisswanger, H. 1981: Pyruvate dehydrogenase component of the pyruvate dehydrogenase complex from Escherichia coli K12. Purification and characterization. European Journal of Biochemistry 114(2): 407-411

Vogel, O.; Henning, U. 1971: Pyruvate dehydrogenase component subunit structure of the Escherichia coli K 12 pyruvate dehydrogenase complex. European Journal of Biochemistry 18(1): 103-115

Hansen, L.L.; Horn, N.; Dahl, H.H.; Kruse, T.A. 1994: Pyruvate dehydrogenase deficiency caused by a 33 base pair duplication in the PDH E1 alpha subunit. Human Molecular Genetics 3(6): 1021-1022

Lissens, W.; Desguerre, I.; Benelli, C.; Marsac, C.; Fouque, F.; Haenggeli, C.; Ponsot, G.; Seneca, S.; Liebaers, I.; De Meirleir, L. 1995: Pyruvate dehydrogenase deficiency in a female due to a 4 base pair deletion in exon 10 of the E1 alpha gene. Human Molecular Genetics 4(2): 307-308

Kerbey, A.L.; Randle, P.J. 1982: Pyruvate dehydrogenase kinase/activator in rat heart mitochondria, Assay, effect of starvation, and effect of protein-synthesis inhibitors of starvation. Biochemical Journal 206(1): 103-111

Danson, M.J.; Porteous, C.E. 1981: Pyruvate dehydrogenase multienzyme complex of Escherichia coli: determination of the Mr of the lipoate acetyltransferase component. Febs Letters 133(1): 112-114

Pettit, F.H.; Teague, W.M.; Reed, L.J. 1982: Pyruvate dehydrogenase phosphatase from bovine heart. Methods in Enzymology 90 Pt E: 402-407

Sheu, K.F.; Blass, J.P. 1984: Pyruvate dehydrogenase phosphate (PDHb) phosphatase activity in fibroblasts from Leigh's disease. Neurology 34(9): 1187-1191

Sheu, K.F.; Lai, J.C.; Blass, J.P. 1983: Pyruvate dehydrogenase phosphate (PDHb) phosphatase in brain: activity, properties, and subcellular localization. Journal of Neurochemistry 40(5): 1366-1372

Matuda, S.; Kitano, A.; Sakaguchi, Y.; Yoshino, M.; Saheki, T. 1984: Pyruvate dehydrogenase subcomplex with lipoamide dehydrogenase deficiency in a patient with lactic acidosis and branched chain ketoaciduria. Clinica Chimica Acta; International Journal of Clinical Chemistry 140(1): 59-64

Bremer, J. 1969: Pyruvate dehydrogenase, substrate specificity and product inhibition. European Journal of Biochemistry 8(4): 535-540

Paniker, N.V.; Beutler, E. 1971: Pyruvate effect in maintenance of ATP and 2,3-DPG of stored blood. Journal of Laboratory and Clinical Medicine 78(3): 472-482

Jungermann, K.; Schön, G. 1974: Pyruvate formate lyase in Rhodospirillum rubrum Ha adapted to anaerobic dark conditions. Archives of Microbiology 99(2): 109-116

Conradt, H.; Hohmann-Berger, M.; Hohmann, H.P.; Blaschkowski, H.P.; Knappe, J. 1984: Pyruvate formate-lyase (inactive form) and pyruvate formate-lyase activating enzyme of Escherichia coli: isolation and structural properties. Archives of Biochemistry and Biophysics 228(1): 133-142

Knappe, J.; Blaschkowski, H.P.; Gröbner, P.; Schmitt, T. 1974: Pyruvate formate-lyase of Escherichia coli: the acetyl-enzyme intermediate. European Journal of Biochemistry 50(1): 253-263

Knappe, J.; Schacht, J.; Möckel, W.; Höpner, T.; Vetter, H.; Edenharder, R. 1969: Pyruvate formate-lyase reaction in Escherichia coli. the enzymatic system converting an inactive form of the lyase into the catalytically active enzyme. European Journal of Biochemistry 11(2): 316-327

Sundaram, T.K.; Cazzulo, J.J.; Kornberg, H.L. 1971: Pyruvate holocarboxylase formation from the apoenzyme and D-biotin in Saccharomyces cerevisiae. Archives of Biochemistry and Biophysics 143(2): 609-616

Van Zanten, A.P.; Verbeek, K.A. 1984: Pyruvate interference in RA 1000 single-reagent AST method. Clinical Chemistry 30(11): 1883

Kanno, H. 1995: Pyruvate kinase (PK) isozyme switching and genetic heterogeneity of PK deficiency. Nihon Rinsho. Japanese Journal of Clinical Medicine 53(5): 1213-1220

Hahn, P.; Houstĕk, J. 1969: Pyruvate kinase activity in brain, liver and brown adipose tissue and the effect of cortisone in suckling rats. Experientia 25(3): 245-246

Azzout, B.; Peret, J. 1984: Pyruvate kinase activity in isolated rat hepatocytes during a feeding cycle and during fasting. Diabete and Metabolisme 10(3): 165-170

Wilson, O.B.; Grün, E. 1984: Pyruvate kinase activity in organs of swine of different ages. Archiv für Experimentelle Veterinarmedizin 38(4): 621-628

Kasakura, E. 1965: Pyruvate kinase activity in serum of patients with hepatic disease. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 54(1): 34-41

Wren, S.F.; Crowe, M.; Lowe, P.J.; de Bold, P.J. 1980: Pyruvate kinase activity in the lymphocytes of malnourished, anergic patients. Journal of Surgical Research 29(3): 203-208

Maj, S.; Pawelski, S. 1968: Pyruvate kinase activity of erythrocytes in hereditary non-spherocytic hemolytic anemias. Polskie Archiwum Medycyny Wewnetrznej 40(5): 587-589

Cottreau, D.; Rousseau-Merck, M.F.; Nezelof, C.; Kahn, A. 1982: Pyruvate kinase and phosphofructokinase isozymes in childhood cancers. Pediatric Research 16(3): 199-202

Höfer, M.; Becker, J.U.; Brand, K.; Deckner, K. 1970: Pyruvate kinase and phosphopyruvate carboxylase in stationary cells of Rhodotorula gracilis. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 351(3): 281

Staal, G.E.; Jansen, G.; Roos, D. 1984: Pyruvate kinase and the "high ATP syndrome". Journal of Clinical Investigation 74(1): 231-235

Van Veelen, C.W.; Verbiest, H.; Zülch, K.J.; van Ketel, B.; van der Vlist, M.J.; Vlug, A.M.; Rijksen, G.; Staal, G.E. 1980: Pyruvate kinase as a marker of human brain tumors. Nederlands Tijdschrift Voor Geneeskunde 124(40): 1678-1685

Porter, D.J.; Ash, D.E.; Bright, H.J. 1983: Pyruvate kinase catalyzed phosphorylation of 3-nitro-2-hydroxypropionate by ATP and concomitant inactivation of the enzyme. Archives of Biochemistry and Biophysics 222(1): 200-206

Miwa, S. 1973: Pyruvate kinase deficiciency. Japanese Journal of Clinical Hematology 14: 1325-1330

Miwa, S. 1981: Pyruvate kinase deficiency and other enzymopathies of the Embden--Meyerhof pathway. Clinics in Haematology 10(1): 57-80

Jacobasch, G.; Syllm-Rapoport, I.; Scharfschwerdt, H.; Otto, F.M.; Pester, H. 1965: Pyruvate kinase deficiency and some problems of glycolysis regulation. Folia Haematologica 83(4): 407-415

Shinohara, K.; Tanaka, K.R. 1980: Pyruvate kinase deficiency hemolytic anemia: enzymatic characterization studies in twelve patients. Hemoglobin 4(5-6): 611-625

Degli Esposti, A.; Ambrosioni, G.; Bonfiglioli, G.; Laghi, M.G. 1971: Pyruvate kinase deficiency in a patient with beta-thalassemia. La Clinica Pediatrica 53(7): 245-259

Gasser, C.; Marti, H.R. 1966: Pyruvate kinase deficiency in hereditary, non-spherocytic hemolytic anemia. Schweizerische Medizinische Wochenschrift 96(38): 1264-1267

Helbig, W.; Pester, F.; Jacobasch, G. 1971: Pyruvate kinase deficiency in the German Democratic Republic. Folia Haematologica 96(1): 68-72

Schwarzmeier, J.; Moser, K.; Lujf, A. 1971: Pyruvate kinase deficiency of erythrocytes in a case of hereditary myopathy. Klinische Wochenschrift 49(3): 156-158

Grann, V. 1974: Pyruvate kinase deficiency--a variant. Connecticut Medicine 38(7): 345-347

Dente, L.; D'Urso, M.; Di Maio, S.; Brancaccio, V.; Luzzatto, L. 1982: Pyruvate kinase deficiency: characterization of two new genetic variants. Clinica Chimica Acta; International Journal of Clinical Chemistry 126(2): 143-154

Drozd, J.W. 1973: Pyruvate kinase from Hydrogenomonas H 16. Febs Letters 37(1): 109-111

Cardenas, J.M. 1982: Pyruvate kinase from bovine muscle and liver. Methods in Enzymology 90 Pt E: 140-149

Kutzbach, C.; Bischofberger, H.; Hess, B.; Zimmermann-Telschow, H. 1973: Pyruvate kinase from pig liver. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 354(10-11): 1473-1489

Nakatani, J.; Nakagawa, Y.; Nakagawa, H.; Manda, A.; Yamanda, S. 1980: Pyruvate kinase from the liver of tumor-bearing rat. Josai Shika Daigaku Kiyo. Bulletin of the Josai Dental University 1(9): 1-5

Cammarota, H.E.; Eladio Vazquez, P.; Castro, C.; Rosenthal, R. 1972: Pyruvate kinase in acute myocardial infarct. Prensa Medica Argentina 59(4): 148-154

Edwards, R.J.; Rodeck, C.H.; Watts, D.C. 1984: Pyruvate kinase in fetal plasma and amniotic fluid unsuccessful for the prenatal diagnosis of Duchenne muscular dystrophy. American Journal of Medical Genetics 18(2): 231-235

Bacigalupo, G.; Meraner, R. 1984: Pyruvate kinase in human amniotic fluid--a new indicator of fetal maturity in late pregnancy. Journal of Perinatal Medicine 12(2): 97-99

Blume, K.G.; Löhr, G.W.; Schalhorn, A. 1968: Pyruvate kinase in human erythrocytes. Lancet 1(7541): 529-530

Mandrik, K.A.; Iarotskiĭ, I.V.; Nefedov, L.I.; Vinogradov, V.V. 1984: Pyruvate kinase in the bovine adrenal cortex. Biokhimiia 49(8): 1295-1299

Kozhevnikova, K.A. 1973: Pyruvate kinase isoenzymes from the cortical and medullary layers of the rabbit kidney. Biokhimiia 38(4): 670-676

Ngo, J.L.; Garratt, K.N.; Eversole, P.; Orlando, R.A.; Ibsen, K.H. 1984: Pyruvate kinase isoenzymes in human serum. Clinical Chemistry 30(1): 111-113

Harano, Y.; Adair, R.; Vignos, P.J.; Miller, M.; Kowal, J. 1973: Pyruvate kinase isoenzymes in progressive muscular dystrophy and in acute myocardial infarction. Metabolism, Clinical and Experimental 22(3): 493-501

Paglia, D.E.; Valentine, W.N.; Holbrook, C.T.; Brockway, R. 1983: Pyruvate kinase isozyme (PK-Greenville) with defective allosteric activation by fructose-1,6-diphosphate: the role of F-1,6-P modulation in normal erythrocyte metabolism. Blood 62(5): 972-979